{
  "name": "Neeraj Narula",
  "first_name": "Neeraj",
  "last_name": "Narula",
  "middle_names": "",
  "title": "Associate Professor, Medicine",
  "photo_url": "https://experts.mcmaster.ca/harvestedImages/fullImages/305.jpg",
  "email": "narulan@mcmaster.ca",
  "websites": [],
  "linkedin": "",
  "twitter": "",
  "websites_json": "[]",
  "primary_website": "",
  "overview": "Dr. Neeraj Narula is an Associate Professor of Medicine at McMaster University and Staff Gastroenterologist at Hamilton Health Sciences, with a clinical and research focus in Inflammatory Bowel Diseases (IBD).He completed the Present-Levison Advanced Inflammatory Bowel Diseases Fellowship at Mount Sinai Hospital (New York, NY) in 2015 and a Masters of Public Health at Harvard TH Chan School of Public Health (Boston, MA) in 2018.He has over 140 peer-reviewed publications and 4 book chapters.  He has been awarded over $3 million in research funding and grants.  His research interests are predominantly in clinical epidemiology, nutrition, and pharmaceutical trials in IBD.He maintains leadership roles within several national organizations, including President of the Canadian IBD Research Consortium and VP-Treasurer for the Canadian Association of Gastroenterology.  His recent awards include the Meeting of the Minds Junior Investigator Award (2020) and Crohn’s and Colitis Rising Star Award (2019).",
  "affiliations_json": "[{\"organizations\": \"Faculty of Health Sciences > McMaster University\"}, {\"position\": \"Associate Member\", \"organizations\": \"Health Research Methods, Evidence, and Impact > Faculty of Health Sciences\"}, {\"position\": \"Associate Professor\", \"organizations\": \"Medicine > Faculty of Health Sciences\"}]",
  "all_affiliations": "Faculty of Health Sciences > McMaster University ; Associate Member, Health Research Methods, Evidence, and Impact > Faculty of Health Sciences ; Associate Professor, Medicine > Faculty of Health Sciences",
  "all_organizations": "Faculty of Health Sciences > McMaster University ; Health Research Methods, Evidence, and Impact > Faculty of Health Sciences ; Medicine > Faculty of Health Sciences",
  "primary_affiliation": "Faculty of Health Sciences > McMaster University",
  "primary_position": "",
  "research_areas": "",
  "research_areas_json": "[]",
  "education_json": "[]",
  "all_degrees": "",
  "all_degrees_only": "",
  "all_institutions": "",
  "highest_degree": "",
  "degree_institution": "",
  "total_publications": 223,
  "journal_articles_count": 179,
  "book_chapters_count": 0,
  "conference_papers_count": 43,
  "recent_publications_count": 131,
  "publications_json": "{\"journal_articles\": [{\"title\": \"Validation of the Modified Multiplier of SES-CD (MM-SES-CD) to Predict Endoscopic Healing in Crohn's Disease: A Post Hoc Analysis of the SEAVUE Trial.\", \"url\": \"https://experts.mcmaster.ca/display/publication3602012\", \"journal\": \"Inflammatory Bowel Diseases\", \"year\": \"2025\", \"doi\": \"10.1093/ibd/izaf137\"}, {\"title\": \"Comparative Predictive Utility of MM-SES-CD and SES-CD for Week 52 Endoscopic Remission in the Ileum and Colon in Crohn's Disease.\", \"url\": \"https://experts.mcmaster.ca/display/publication3596640\", \"journal\": \"Inflammatory Bowel Diseases\", \"year\": \"2025\", \"doi\": \"10.1093/ibd/izaf124\"}, {\"title\": \"Effectiveness and Safety of Advanced Combination Treatment in Patients With Refractory Inflammatory Bowel Disease or Concomitant Immune-Mediated Disease or Extraintestinal Manifestations: A Multicenter Canadian Study.\", \"url\": \"https://experts.mcmaster.ca/display/publication3591258\", \"journal\": \"American Journal of Gastroenterology\", \"year\": \"2025\", \"doi\": \"10.14309/ajg.0000000000003573\"}, {\"title\": \"Comparative Efficacy of Biologics and Small Molecule Therapies in Improving Patient-Reported Outcomes in Ulcerative Colitis: Systematic Review and Network Meta-Analysis\", \"url\": \"https://experts.mcmaster.ca/display/publication3459078\", \"journal\": \"Inflammatory Bowel Diseases\", \"year\": \"2025\", \"doi\": \"10.1093/ibd/izae163\"}, {\"title\": \"Definitions, diagnosis, and management of postoperative recurrence in Crohn's disease patients with permanent ileostomy-a systematic review and meta-analysis.\", \"url\": \"https://experts.mcmaster.ca/display/publication3554630\", \"journal\": \"Journal of Crohn's and Colitis\", \"year\": \"2025\", \"doi\": \"10.1093/ecco-jcc/jjaf041\"}, {\"title\": \"Novel outcomes in inflammatory bowel disease.\", \"url\": \"https://experts.mcmaster.ca/display/publication3554829\", \"journal\": \"Journal of Crohn's and Colitis\", \"year\": \"2025\", \"doi\": \"10.1093/ecco-jcc/jjaf040\"}, {\"title\": \"Use of Modified Multiplier of the Simple Endoscopic Score for Crohn's Disease Endoscopic Improvement Thresholds Enhances Effect Size Differentiation Between Adalimumab Versus Placebo: A Post Hoc Analysis of the EXTEND Trial.\", \"url\": \"https://experts.mcmaster.ca/display/publication3486406\", \"journal\": \"Journal of Crohn's and Colitis\", \"year\": \"2025\", \"doi\": \"10.1093/ecco-jcc/jjae171\"}, {\"title\": \"Treat-to-target of endoscopic remission in patients with inflammatory bowel disease in symptomatic remission on advanced therapies (QUOTIENT): rationale, design and protocol for an open-label, multicentre, pragmatic, randomised controlled trial.\", \"url\": \"https://experts.mcmaster.ca/display/publication3562762\", \"journal\": \"BMJ Open Gastroenterology\", \"year\": \"2025\", \"doi\": \"10.1136/bmjgast-2024-001615\"}, {\"title\": \"Outcomes of Patients With Prior Biologic Intolerance Are Better Than Those With Biologic Failure in Clinical Trials of Inflammatory Bowel Disease.\", \"url\": \"https://experts.mcmaster.ca/display/publication3472663\", \"journal\": \"Journal of Crohn's and Colitis\", \"year\": \"2025\", \"doi\": \"10.1093/ecco-jcc/jjae151\"}, {\"title\": \"A Review of the Modified Multiplier of Simple Endoscopic Score for Crohn's Disease and How to Use It in Clinical Trials and Practice.\", \"url\": \"https://experts.mcmaster.ca/display/publication3545273\", \"journal\": \"American Journal of Gastroenterology\", \"year\": \"2025\", \"doi\": \"10.14309/ajg.0000000000003373\"}, {\"title\": \"Placebo Rates in Crohn's Disease Randomized Clinical Trials: An Individual Patient Data Meta-Analysis.\", \"url\": \"https://experts.mcmaster.ca/display/publication3478275\", \"journal\": \"Gastroenterology\", \"year\": \"2025\", \"doi\": \"10.1053/j.gastro.2024.10.009\"}, {\"title\": \"Improvement in serum eosinophilia is observed in clinical responders to ustekinumab but not adalimumab in inflammatory bowel disease.\", \"url\": \"https://experts.mcmaster.ca/display/publication3525394\", \"journal\": \"Journal of Crohn's and Colitis\", \"year\": \"2025\", \"doi\": \"10.1093/ecco-jcc/jjaf006\"}, {\"title\": \"Tofacitinib for Hospitalized Acute Severe Ulcerative Colitis Management (The TRIUMPH Study).\", \"url\": \"https://experts.mcmaster.ca/display/publication3558304\", \"journal\": \"Crohn's and Colitis 360\", \"year\": \"2025\", \"doi\": \"10.1093/crocol/otaf013\"}, {\"title\": \"Using Diet to Treat Inflammatory Bowel Disease: A Systematic Review\", \"url\": \"https://experts.mcmaster.ca/display/publication3452270\", \"journal\": \"American Journal of Gastroenterology\", \"year\": \"2025\", \"doi\": \"10.14309/ajg.0000000000002973\"}, {\"title\": \"Acceptability, feasibility, and impact of the MyGut digital health platform in the monitoring and management of inflammatory bowel disease.\", \"url\": \"https://experts.mcmaster.ca/display/publication3504743\", \"journal\": \"Journal of the Canadian Association of Gastroenterology\", \"year\": \"2024\", \"doi\": \"10.1093/jcag/gwae029\"}, {\"title\": \"Clinical Trial Design Considerations for Hospitalised Patients With Ulcerative Colitis Flares and Application to Study Hyperbaric Oxygen Therapy in the NIDDK HBOT-UC Consortium.\", \"url\": \"https://experts.mcmaster.ca/display/publication3480443\", \"journal\": \"Alimentary Pharmacology and Therapeutics\", \"year\": \"2024\", \"doi\": \"10.1111/apt.18326\"}, {\"title\": \"Corrigendum to \\\"Differential efficacy of medical therapies for ulcerative colitis according to disease extent: patient-level analysis from multiple randomized controlled trials\\\" volume\\u00a072, 102621.\", \"url\": \"https://experts.mcmaster.ca/display/publication3494533\", \"journal\": \"EClinicalMedicine\", \"year\": \"2024\", \"doi\": \"10.1016/j.eclinm.2024.102980\"}, {\"title\": \"Effectiveness of Ustekinumab for Patients With Moderate-to-Severe Ulcerative Colitis: A Multicenter Real-World Canadian Study.\", \"url\": \"https://experts.mcmaster.ca/display/publication3504742\", \"journal\": \"American Journal of Gastroenterology\", \"year\": \"2024\", \"doi\": \"10.14309/ajg.0000000000003212\"}, {\"title\": \"Preliminary Results From a Multicenter, Randomized Trial Using Fecal Microbiota Transplantation to Induce Remission in Patients With Mild-to-Moderate Crohn's Disease.\", \"url\": \"https://experts.mcmaster.ca/display/publication3488203\", \"journal\": \"American Journal of Gastroenterology\", \"year\": \"2024\", \"doi\": \"10.14309/ajg.0000000000003196\"}, {\"title\": \"Perspectives on the sustained engagement with digital health tools: protocol for a qualitative interview study among people living with Inflammatory Bowel Disease or irritable bowel syndrome.\", \"url\": \"https://experts.mcmaster.ca/display/publication3488435\", \"journal\": \"BMJ Open\", \"year\": \"2024\", \"doi\": \"10.1136/bmjopen-2024-089220\"}, {\"title\": \"Characteristics of Interventional Trials for Patients Living With Intestinal Stoma Registered in ClinicalTrials.gov With a Focus on Inflammatory Bowel Disease\", \"url\": \"https://experts.mcmaster.ca/display/publication3384673\", \"journal\": \"Inflammatory Bowel Diseases\", \"year\": \"2024\", \"doi\": \"10.1093/ibd/izad293\"}, {\"title\": \"Interventions for Adjunctive Care in Patients With Inflammatory Bowel Disease and Permanent Ileostomy: A Systematic Review.\", \"url\": \"https://experts.mcmaster.ca/display/publication3479873\", \"journal\": \"Crohn's and Colitis 360\", \"year\": \"2024\", \"doi\": \"10.1093/crocol/otae056\"}, {\"title\": \"Management of complications in patients with an ileostomy: an umbrella review of systematic reviews for the EndOTrial Consortium.\", \"url\": \"https://experts.mcmaster.ca/display/publication3472532\", \"journal\": \"International Journal of Colorectal Disease\", \"year\": \"2024\", \"doi\": \"10.1007/s00384-024-04714-8\"}, {\"title\": \"Defining Endoscopic Remission in Crohn\\u2019s Disease: MM-SES-CD and SES-CD Thresholds Associated With Low Risk of Disease Progression\", \"url\": \"https://experts.mcmaster.ca/display/publication3403343\", \"journal\": \"Clinical Gastroenterology and Hepatology\", \"year\": \"2024\", \"doi\": \"10.1016/j.cgh.2024.02.009\"}, {\"title\": \"Early Biologic Treatment Decreases Risk of Surgery in Crohn\\u2019s Disease but not in Ulcerative Colitis: Systematic Review and Meta-Analysis\", \"url\": \"https://experts.mcmaster.ca/display/publication3276973\", \"journal\": \"Inflammatory Bowel Diseases\", \"year\": \"2024\", \"doi\": \"10.1093/ibd/izad149\"}, {\"title\": \"Delayed Ustekinumab and Adalimumab Responders Have Similar Outcomes as Early Responders in Biologic-Na\\u00efve Crohn's Disease\", \"url\": \"https://experts.mcmaster.ca/display/publication3389726\", \"journal\": \"American Journal of Gastroenterology\", \"year\": \"2024\", \"doi\": \"10.14309/ajg.0000000000002654\"}, {\"title\": \"Comparative Efficacy of Advanced Therapies for Achieving Endoscopic Outcomes in Crohn\\u2019s Disease: A Systematic Review and Network Meta-Analysis\", \"url\": \"https://experts.mcmaster.ca/display/publication3386633\", \"journal\": \"Clinical Gastroenterology and Hepatology\", \"year\": \"2024\", \"doi\": \"10.1016/j.cgh.2023.12.023\"}, {\"title\": \"Comparing the efficacy of vedolizumab between males and females: a post-hoc analysis of GEMINI-1 and VARSITY\", \"url\": \"https://experts.mcmaster.ca/display/publication3409104\", \"journal\": \"European Journal of Gastroenterology and Hepatology\", \"year\": \"2024\", \"doi\": \"10.1097/meg.0000000000002759\"}, {\"title\": \"Differential efficacy of medical therapies for ulcerative colitis according to disease extent: patient-level analysis from multiple randomized controlled trials\", \"url\": \"https://experts.mcmaster.ca/display/publication3427026\", \"journal\": \"EClinicalMedicine\", \"year\": \"2024\", \"doi\": \"10.1016/j.eclinm.2024.102621\"}, {\"title\": \"Resolution of rectal bleeding by day 7 in acute severe ulcerative colitis is prognostic for post-discharge corticosteroid free clinical remission and endoscopic improvement\", \"url\": \"https://experts.mcmaster.ca/display/publication3431652\", \"journal\": \"American Journal of Gastroenterology\", \"year\": \"2024\", \"doi\": \"10.14309/ajg.0000000000002860\"}, {\"title\": \"Healthcare resource utilization following ustekinumab initiation among bio-na\\u00efve Canadian patients with moderately-to-severely active Crohn's disease\", \"url\": \"https://experts.mcmaster.ca/display/publication3437413\", \"journal\": \"Digestive and Liver Disease\", \"year\": \"2024\", \"doi\": \"10.1016/j.dld.2024.04.017\"}, {\"title\": \"Pharmacological Therapies for the Management of Fistulizing Crohn\\u2019s Disease: A Systematic Review and Meta-Analysis\", \"url\": \"https://experts.mcmaster.ca/display/publication3307352\", \"journal\": \"Journal of Crohn's and Colitis\", \"year\": \"2024\", \"doi\": \"10.1093/ecco-jcc/jjad185\"}, {\"title\": \"Endoscopic and Histological Placebo Rates in Crohn\\u2019s Disease Clinical Trials: A Systematic Review and Meta-analysis\", \"url\": \"https://experts.mcmaster.ca/display/publication3010261\", \"journal\": \"Inflammatory Bowel Diseases\", \"year\": \"2024\", \"doi\": \"10.1093/ibd/izad052\"}, {\"title\": \"Integrating Evidence to Guide Use of Biologics and Small Molecules for Inflammatory Bowel Diseases\", \"url\": \"https://experts.mcmaster.ca/display/publication3309164\", \"journal\": \"Gastroenterology\", \"year\": \"2024\", \"doi\": \"10.1053/j.gastro.2023.10.033\"}, {\"title\": \"Predicting Endoscopic Improvement in Ulcerative Colitis Using the Ulcerative Colitis Severity Index\", \"url\": \"https://experts.mcmaster.ca/display/publication3190786\", \"journal\": \"Inflammatory Bowel Diseases\", \"year\": \"2024\", \"doi\": \"10.1093/ibd/izad074\"}, {\"title\": \"Matching-adjusted Indirect Comparisons vs Propensity Score Matching with Individual Patient-level Data to Estimate Treatment Efficacy\", \"url\": \"https://experts.mcmaster.ca/display/publication3242731\", \"journal\": \"Inflammatory Bowel Diseases\", \"year\": \"2024\", \"doi\": \"10.1093/ibd/izad077\"}, {\"title\": \"Histological Remission Placebo Rates in Ulcerative Colitis Trials: A Systematic Review and Meta-analysis\", \"url\": \"https://experts.mcmaster.ca/display/publication2922723\", \"journal\": \"Inflammatory Bowel Diseases\", \"year\": \"2024\", \"doi\": \"10.1093/ibd/izad013\"}, {\"title\": \"Editorial: Moving towards prognostic endoscopic scoring in IBD\", \"url\": \"https://experts.mcmaster.ca/display/publication3324567\", \"journal\": \"Alimentary Pharmacology and Therapeutics\", \"year\": \"2024\", \"doi\": \"10.1111/apt.17787\"}, {\"title\": \"Patient Experience with the SensoReady\\u00ae Autoinjector Pen versus a Comparator Device: Results from a Canadian Patient Survey in Rheumatoid Arthritis and Crohn\\u00b4s Disease\", \"url\": \"https://experts.mcmaster.ca/display/publication3441719\", \"journal\": \"Patient Preference and Adherence\", \"year\": \"2024\", \"doi\": \"10.2147/ppa.s455791\"}, {\"title\": \"Real-world effectiveness and safety of ustekinumab in bio-naive patients with moderate-to-severe Crohn's disease: A Canadian multi-center study\", \"url\": \"https://experts.mcmaster.ca/display/publication3294107\", \"journal\": \"Digestive and Liver Disease\", \"year\": \"2024\", \"doi\": \"10.1016/j.dld.2023.08.042\"}, {\"title\": \"Delayed Ustekinumab Responders in Ulcerative Colitis Have Greater Inflammatory Burden but Similar Outcomes as Early Responders\", \"url\": \"https://experts.mcmaster.ca/display/publication3258356\", \"journal\": \"Clinical Gastroenterology and Hepatology\", \"year\": \"2023\", \"doi\": \"10.1016/j.cgh.2023.06.011\"}, {\"title\": \"Efficacy and Safety of Advanced Oral Small Molecules for Inflammatory Bowel Disease: Systematic Review and Meta-Analysis\", \"url\": \"https://experts.mcmaster.ca/display/publication3251431\", \"journal\": \"Journal of Crohn's and Colitis\", \"year\": \"2023\", \"doi\": \"10.1093/ecco-jcc/jjad100\"}, {\"title\": \"Baseline Patient-reported Symptoms Less Predictive Than MM-SES-CD for Endoscopic Remission in Crohn\\u2019s Disease\", \"url\": \"https://experts.mcmaster.ca/display/publication3242733\", \"journal\": \"Journal of Clinical Gastroenterology\", \"year\": \"2023\", \"doi\": \"10.1097/mcg.0000000000001774\"}, {\"title\": \"Predictors of histologic response to mepolizumab in pediatric eosinophilic esophagitis\", \"url\": \"https://experts.mcmaster.ca/display/publication3281920\", \"journal\": \"European Journal of Gastroenterology and Hepatology\", \"year\": \"2023\", \"doi\": \"10.1097/meg.0000000000002623\"}, {\"title\": \"Systematic review with meta\\u2010analysis: Medical therapies for treatment of ulcerative proctitis\", \"url\": \"https://experts.mcmaster.ca/display/publication3281919\", \"journal\": \"Alimentary Pharmacology and Therapeutics\", \"year\": \"2023\", \"doi\": \"10.1111/apt.17666\"}, {\"title\": \"The current role of Tofacitinib in acute severe ulcerative colitis in adult patients: A systematic review\", \"url\": \"https://experts.mcmaster.ca/display/publication3253726\", \"journal\": \"Digestive and Liver Disease\", \"year\": \"2023\", \"doi\": \"10.1016/j.dld.2023.05.021\"}, {\"title\": \"Associations of Antibiotics, Hormonal Therapies, Oral Contraceptives, and Long-Term NSAIDS With Inflammatory Bowel Disease: Results From the Prospective Urban Rural Epidemiology (PURE) Study\", \"url\": \"https://experts.mcmaster.ca/display/publication2951618\", \"journal\": \"Clinical Gastroenterology and Hepatology\", \"year\": \"2023\", \"doi\": \"10.1016/j.cgh.2022.11.037\"}, {\"title\": \"Efficacy and Safety of IL-12/23 and IL-23 Inhibitors for Crohn\\u2019s Disease: Systematic Review and Meta-Analysis\", \"url\": \"https://experts.mcmaster.ca/display/publication3255545\", \"journal\": \"Digestive Diseases and Sciences\", \"year\": \"2023\", \"doi\": \"10.1007/s10620-023-08014-z\"}, {\"title\": \"Food Processing and Risk of Inflammatory Bowel Disease: A\\u00a0Systematic Review and Meta-Analysis\", \"url\": \"https://experts.mcmaster.ca/display/publication3068329\", \"journal\": \"Clinical Gastroenterology and Hepatology\", \"year\": \"2023\", \"doi\": \"10.1016/j.cgh.2023.01.012\"}, {\"title\": \"Predictors of Clinical Remission to Placebo in Clinical Trials of Crohn\\u2019s Disease\", \"url\": \"https://experts.mcmaster.ca/display/publication2579479\", \"journal\": \"Inflammatory Bowel Diseases\", \"year\": \"2023\", \"doi\": \"10.1093/ibd/izac231\"}, {\"title\": \"Vedolizumab does not increase risk of clostridium difficile infection in patients with inflammatory bowel disease using vedolizumab: A retrospective cohort study\", \"url\": \"https://experts.mcmaster.ca/display/publication3284392\", \"journal\": \"Saudi Pharmaceutical Journal\", \"year\": \"2023\", \"doi\": \"10.1016/j.jsps.2023.101736\"}, {\"title\": \"Ulcer Size After Induction Therapy Performs Better Than Symptom Assessment for Prediction of One Year Endoscopic Remission in Crohn\\u2019s Disease: A Post Hoc Analysis\", \"url\": \"https://experts.mcmaster.ca/display/publication2435761\", \"journal\": \"Inflammatory Bowel Diseases\", \"year\": \"2023\", \"doi\": \"10.1093/ibd/izac210\"}, {\"title\": \"Combined Histological and Endoscopic Endpoints at Post-induction Lack Additional Prognostic Value Compared with Endoscopic Improvement Alone in Ulcerative Colitis: A Post hoc Analysis of the VARSITY study\", \"url\": \"https://experts.mcmaster.ca/display/publication2864764\", \"journal\": \"Journal of Crohn's and Colitis\", \"year\": \"2023\", \"doi\": \"10.1093/ecco-jcc/jjad033\"}, {\"title\": \"Comparative Efficacy of Infliximab vs Ustekinumab for Maintenance of Clinical Response in Biologic Na\\u00efve Crohn\\u2019s Disease\", \"url\": \"https://experts.mcmaster.ca/display/publication2423411\", \"journal\": \"Inflammatory Bowel Diseases\", \"year\": \"2023\", \"doi\": \"10.1093/ibd/izac168\"}, {\"title\": \"Declining Enrolment and Other Challenges in IBD Clinical Trials: Causes and Potential Solutions\", \"url\": \"https://experts.mcmaster.ca/display/publication2864765\", \"journal\": \"Journal of Crohn's and Colitis\", \"year\": \"2023\", \"doi\": \"10.1093/ecco-jcc/jjad020\"}, {\"title\": \"Patients With Crohn's Disease and Permanent Ileostomy Are Universally Excluded From Clinical Trials: A Systematic Review\", \"url\": \"https://experts.mcmaster.ca/display/publication2835522\", \"journal\": \"American Journal of Gastroenterology\", \"year\": \"2023\", \"doi\": \"10.14309/ajg.0000000000002215\"}, {\"title\": \"Comparative Efficacy of Infliximab Versus Tofacitinib for Inducing Remission in Biologic Naive Ulcerative Colitis: A Propensity Matched Study\", \"url\": \"https://experts.mcmaster.ca/display/publication3127668\", \"journal\": \"Digestive Diseases and Sciences\", \"year\": \"2023\", \"doi\": \"10.1007/s10620-023-07956-8\"}, {\"title\": \"Increased Expression of Interleukin-13 Receptor in Ileum Associated With Nonresponse to Adalimumab in Ileal Crohn\\u2019s Disease\", \"url\": \"https://experts.mcmaster.ca/display/publication2421127\", \"journal\": \"Inflammatory Bowel Diseases\", \"year\": \"2023\", \"doi\": \"10.1093/ibd/izac157\"}, {\"title\": \"Vedolizumab and Adalimumab in Biologic-Na\\u00efve Ulcerative Colitis: Comparison of Patient-Level Clinical Trial Data and VARSITY for Week 6 Clinical Remission\", \"url\": \"https://experts.mcmaster.ca/display/publication2746201\", \"journal\": \"Digestive Diseases and Sciences\", \"year\": \"2023\", \"doi\": \"10.1007/s10620-023-07825-4\"}, {\"title\": \"REMIT-UC: Real-World Effectiveness and Safety of Tofacitinib for Moderate-to-Severely Active Ulcerative Colitis\", \"url\": \"https://experts.mcmaster.ca/display/publication3239421\", \"journal\": \"American Journal of Gastroenterology\", \"year\": \"2023\", \"doi\": \"10.14309/ajg.0000000000002129\"}, {\"title\": \"Placebo Response Rates in Randomized Controlled Trials for Perianal Crohn\\u2019s Disease: A Systematic Review and Meta-Analysis\", \"url\": \"https://experts.mcmaster.ca/display/publication2553186\", \"journal\": \"Journal of Crohn's and Colitis\", \"year\": \"2023\", \"doi\": \"10.1093/ecco-jcc/jjac160\"}, {\"title\": \"Beyond the White Pill: Advocating for Racial Diversity in IBD Trials\", \"url\": \"https://experts.mcmaster.ca/display/publication2429670\", \"journal\": \"Journal of Crohn's and Colitis\", \"year\": \"2023\", \"doi\": \"10.1093/ecco-jcc/jjac134\"}, {\"title\": \"Most Placebo-Controlled Trials in Inflammatory Bowel Disease were Underpowered Because of Overestimated Drug Efficacy Rates: Results from a Systematic Review of Induction Studies\", \"url\": \"https://experts.mcmaster.ca/display/publication2435770\", \"journal\": \"Journal of Crohn's and Colitis\", \"year\": \"2023\", \"doi\": \"10.1093/ecco-jcc/jjac150\"}, {\"title\": \"Correspondence on \\u201cPICaSSO Histologic Remission Index (PHRI) in ulcerative colitis: development of a novel simplified histological score for monitoring mucosal healing and predicting clinical outcomes and its applicability in an artificial intelligence system\\u201d by Guiet al\", \"url\": \"https://experts.mcmaster.ca/display/publication2232253\", \"journal\": \"Gut\", \"year\": \"2023\", \"doi\": \"10.1136/gutjnl-2022-327661\"}, {\"title\": \"Predictors of Placebo Induction Response and Remission in Ulcerative Colitis\", \"url\": \"https://experts.mcmaster.ca/display/publication2473035\", \"journal\": \"Clinical Gastroenterology and Hepatology\", \"year\": \"2023\", \"doi\": \"10.1016/j.cgh.2022.08.015\"}, {\"title\": \"Time to Endorse A Sensitive Method for Scoring Endoscopic Activity of Ulcerative Colitis in Clinical Research\", \"url\": \"https://experts.mcmaster.ca/display/publication2429671\", \"journal\": \"Journal of Crohn's and Colitis\", \"year\": \"2023\", \"doi\": \"10.1093/ecco-jcc/jjac120\"}, {\"title\": \"Clinical remission in paired phase two and three studies in inflammatory bowel disease: a systematic review with meta-analysis\", \"url\": \"https://experts.mcmaster.ca/display/publication2777572\", \"journal\": \"European Journal of Gastroenterology and Hepatology\", \"year\": \"2023\", \"doi\": \"10.1097/meg.0000000000002490\"}, {\"title\": \"Comparison of the Relative Sensitivity of Clinical, Endoscopic, and Histologic Remission for Detection of Treatment Efficacy in Ulcerative Colitis Trials\", \"url\": \"https://experts.mcmaster.ca/display/publication2315339\", \"journal\": \"Inflammatory Bowel Diseases\", \"year\": \"2023\", \"doi\": \"10.1093/ibd/izac128\"}, {\"title\": \"The Real-World Effectiveness and Safety of Ustekinumab in the Treatment of Crohn's Disease: Results From the SUCCESS Consortium\", \"url\": \"https://experts.mcmaster.ca/display/publication2835262\", \"journal\": \"American Journal of Gastroenterology\", \"year\": \"2023\", \"doi\": \"10.14309/ajg.0000000000002047\"}, {\"title\": \"The impact of clinical experience on decision-making regarding the treatment and management of mild-to-moderate ulcerative colitis\", \"url\": \"https://experts.mcmaster.ca/display/publication3068328\", \"journal\": \"Intestinal Research\", \"year\": \"2023\", \"doi\": \"10.5217/ir.2022.00006\"}, {\"title\": \"Placebo Rates in Randomized Controlled Trials of Proctitis Therapy: A Systematic Review and Meta-Analysis Placebo Response in Proctitis\", \"url\": \"https://experts.mcmaster.ca/display/publication2429655\", \"journal\": \"Journal of Crohn's and Colitis\", \"year\": \"2023\", \"doi\": \"10.1093/ecco-jcc/jjac109\"}, {\"title\": \"End of induction patient reported outcomes predict clinical remission and endoscopic improvement with vedolizumab and adalimumab in ulcerative colitis\", \"url\": \"https://experts.mcmaster.ca/display/publication2421125\", \"journal\": \"Scandinavian Journal of Gastroenterology\", \"year\": \"2023\", \"doi\": \"10.1080/00365521.2022.2105169\"}, {\"title\": \"Long-Term Outcomes of Early vs Delayed Responders to Vedolizumab and Adalimumab: A Post Hoc Analysis of the VARSITY Study\", \"url\": \"https://experts.mcmaster.ca/display/publication2429672\", \"journal\": \"American Journal of Gastroenterology\", \"year\": \"2023\", \"doi\": \"10.14309/ajg.0000000000001987\"}, {\"title\": \"Pilot study of an elimination diet in adults with mild to moderate Crohn\\u2019s disease\", \"url\": \"https://experts.mcmaster.ca/display/publication2472497\", \"journal\": \"European Journal of Gastroenterology and Hepatology\", \"year\": \"2022\", \"doi\": \"10.1097/meg.0000000000002438\"}, {\"title\": \"Effectiveness of Tofacitinib for Hospitalized Patients with Acute Severe Ulcerative Colitis: Case Series\", \"url\": \"https://experts.mcmaster.ca/display/publication2173066\", \"journal\": \"Digestive Diseases and Sciences\", \"year\": \"2022\", \"doi\": \"10.1007/s10620-022-07439-2\"}, {\"title\": \"Decision Support Tool Identifies Ulcerative Colitis Patients Most Likely to Achieve Remission With Vedolizumab vs Adalimumab\", \"url\": \"https://experts.mcmaster.ca/display/publication2157222\", \"journal\": \"Inflammatory Bowel Diseases\", \"year\": \"2022\", \"doi\": \"10.1093/ibd/izab310\"}, {\"title\": \"Case Report: Managing Postoperative Crohn's Disease.\", \"url\": \"https://experts.mcmaster.ca/display/publication2445203\", \"journal\": \"Gastroenterology and Hepatology\", \"year\": \"2022\"}, {\"title\": \"Week 2 Adalimumab Levels Predict Short-term Clinical Remission in Patients With Inflammatory Bowel Disease\", \"url\": \"https://experts.mcmaster.ca/display/publication2152104\", \"journal\": \"Journal of Clinical Gastroenterology\", \"year\": \"2022\", \"doi\": \"10.1097/mcg.0000000000001636\"}, {\"title\": \"Categorising Endoscopic Severity of Crohn\\u2019s Disease Using the Modified Multiplier SES-CD [MM-SES-CD]\", \"url\": \"https://experts.mcmaster.ca/display/publication2167612\", \"journal\": \"Journal of Crohn's and Colitis\", \"year\": \"2022\", \"doi\": \"10.1093/ecco-jcc/jjac018\"}, {\"title\": \"Comparative Efficacy and Rapidity of Action for Infliximab vs Ustekinumab in Biologic Na\\u00efve Crohn\\u2019s Disease\", \"url\": \"https://experts.mcmaster.ca/display/publication1966171\", \"journal\": \"Clinical Gastroenterology and Hepatology\", \"year\": \"2022\", \"doi\": \"10.1016/j.cgh.2021.04.006\"}, {\"title\": \"Comparative Efficacy for Infliximab Vs Vedolizumab in Biologic Naive Ulcerative Colitis\", \"url\": \"https://experts.mcmaster.ca/display/publication2152404\", \"journal\": \"Clinical Gastroenterology and Hepatology\", \"year\": \"2022\", \"doi\": \"10.1016/j.cgh.2021.07.038\"}, {\"title\": \"Predicting endoscopic remission in Crohn\\u2019s disease by the modified multiplier SES-CD (MM-SES-CD)\", \"url\": \"https://experts.mcmaster.ca/display/publication1964783\", \"journal\": \"Gut\", \"year\": \"2022\", \"doi\": \"10.1136/gutjnl-2020-323799\"}, {\"title\": \"Reply\", \"url\": \"https://experts.mcmaster.ca/display/publication2189441\", \"journal\": \"Clinical Gastroenterology and Hepatology\", \"year\": \"2022\", \"doi\": \"10.1016/j.cgh.2021.08.024\"}, {\"title\": \"Ustekinumab does not increase risk of new or recurrent cancer in inflammatory bowel disease patients with prior malignancy\", \"url\": \"https://experts.mcmaster.ca/display/publication2176323\", \"journal\": \"Journal of Gastroenterology and Hepatology\", \"year\": \"2022\", \"doi\": \"10.1111/jgh.15806\"}, {\"title\": \"Early Reduction in MM-SES-CD Score After Initiation of Biologic Therapy is Highly Specific for 1-year Endoscopic Remission in Moderate to Severe Crohn\\u2019s Disease\", \"url\": \"https://experts.mcmaster.ca/display/publication2157223\", \"journal\": \"Journal of Crohn's and Colitis\", \"year\": \"2022\", \"doi\": \"10.1093/ecco-jcc/jjab183\"}, {\"title\": \"Clinical Decision Support Tool for Infliximab in Crohn\\u2019s Disease\", \"url\": \"https://experts.mcmaster.ca/display/publication1986949\", \"journal\": \"Clinical Gastroenterology and Hepatology\", \"year\": \"2022\", \"doi\": \"10.1016/j.cgh.2021.06.037\"}, {\"title\": \"Early Change in Epithelial Neutrophilic Infiltrate Predicts Long-Term Response to Biologics in Ulcerative Colitis\", \"url\": \"https://experts.mcmaster.ca/display/publication1986950\", \"journal\": \"Clinical Gastroenterology and Hepatology\", \"year\": \"2022\", \"doi\": \"10.1016/j.cgh.2021.07.005\"}, {\"title\": \"Periodic Colonoscopies Are Associated with Improved Survival and Prognosis of Colorectal Cancer in Ulcerative Colitis\", \"url\": \"https://experts.mcmaster.ca/display/publication2048244\", \"journal\": \"Digestive Diseases and Sciences\", \"year\": \"2022\", \"doi\": \"10.1007/s10620-021-07151-7\"}, {\"title\": \"Reply\", \"url\": \"https://experts.mcmaster.ca/display/publication1970900\", \"journal\": \"Clinical Gastroenterology and Hepatology\", \"year\": \"2022\", \"doi\": \"10.1016/j.cgh.2021.05.051\"}, {\"title\": \"Resolution of dominant patient\\u2010reported outcome at end of induction predicts clinical and endoscopic remission in Crohn\\u2019s disease\", \"url\": \"https://experts.mcmaster.ca/display/publication2167611\", \"journal\": \"Alimentary Pharmacology and Therapeutics\", \"year\": \"2022\", \"doi\": \"10.1111/apt.16805\"}, {\"title\": \"Multinational evaluation of clinical decision-making in the treatment and management of mild-to-moderate ulcerative colitis\", \"url\": \"https://experts.mcmaster.ca/display/publication2157229\", \"journal\": \"Scandinavian Journal of Gastroenterology\", \"year\": \"2022\", \"doi\": \"10.1080/00365521.2021.2015801\"}, {\"title\": \"Editorial: is it not justPROs, but the most important individualPRO, that really matters in Crohn\\u2019s disease? Authors\\u2019 reply\", \"url\": \"https://experts.mcmaster.ca/display/publication2182415\", \"journal\": \"Alimentary Pharmacology and Therapeutics\", \"year\": \"2022\", \"doi\": \"10.1111/apt.16866\"}, {\"title\": \"Modelling the benefits of an optimised treatment strategy for 5-ASA in mild-to-moderate ulcerative colitis\", \"url\": \"https://experts.mcmaster.ca/display/publication2173067\", \"journal\": \"BMJ Open Gastroenterology\", \"year\": \"2022\", \"doi\": \"10.1136/bmjgast-2021-000853\"}, {\"title\": \"Host Genetic Determinants Associated With Helicobacter pylori Eradication Treatment Failure: A Systematic Review and Meta-analysis\", \"url\": \"https://experts.mcmaster.ca/display/publication2137006\", \"journal\": \"Gastroenterology\", \"year\": \"2021\", \"doi\": \"10.1053/j.gastro.2021.07.043\"}, {\"title\": \"Outcomes of Passable and Non-passable Strictures in Clinical Trials of Crohn\\u2019s Disease: A Post-hoc Analysis\", \"url\": \"https://experts.mcmaster.ca/display/publication1961799\", \"journal\": \"Journal of Crohn's and Colitis\", \"year\": \"2021\", \"doi\": \"10.1093/ecco-jcc/jjab045\"}, {\"title\": \"Declining Use of Corticosteroids for Crohn\\u2019s Disease Has Implications for Study Recruitment: Results of a Pilot Randomized Controlled Trial\", \"url\": \"https://experts.mcmaster.ca/display/publication2132392\", \"journal\": \"Journal of the Canadian Association of Gastroenterology\", \"year\": \"2021\", \"doi\": \"10.1093/jcag/gwaa037\"}, {\"title\": \"Comparative effectiveness of higher adalimumab maintenance therapyversusstandard dose in anti\\u2010tumor necrosis factor experienced Crohn's disease patients: A propensity\\u2010score matched cohort analysis\", \"url\": \"https://experts.mcmaster.ca/display/publication1970011\", \"journal\": \"Journal of Gastroenterology and Hepatology\", \"year\": \"2021\", \"doi\": \"10.1111/jgh.15551\"}, {\"title\": \"Does a High-inflammatory Diet Increase the Risk of Inflammatory Bowel Disease? Results From the Prospective Urban Rural Epidemiology (PURE) Study: A Prospective Cohort Study\", \"url\": \"https://experts.mcmaster.ca/display/publication1981841\", \"journal\": \"Gastroenterology\", \"year\": \"2021\", \"doi\": \"10.1053/j.gastro.2021.06.007\"}, {\"title\": \"Higher adalimumab maintenance regimen is more effective than standard dose in anti-TNF experienced Crohn\\u2019s disease patients\", \"url\": \"https://experts.mcmaster.ca/display/publication2124125\", \"journal\": \"European Journal of Gastroenterology and Hepatology\", \"year\": \"2021\", \"doi\": \"10.1097/meg.0000000000002250\"}, {\"title\": \"Systematic review and meta\\u2010analysis: Safety of vedolizumab during pregnancy in patients with inflammatory bowel disease\", \"url\": \"https://experts.mcmaster.ca/display/publication1981840\", \"journal\": \"Journal of Gastroenterology and Hepatology\", \"year\": \"2021\", \"doi\": \"10.1111/jgh.15574\"}, {\"title\": \"Prevalence and Progression of Incidental Terminal Ileitis on Non-diagnostic Colonoscopy: A Systematic Review and Meta-analysis\", \"url\": \"https://experts.mcmaster.ca/display/publication1959560\", \"journal\": \"Journal of Crohn's and Colitis\", \"year\": \"2021\", \"doi\": \"10.1093/ecco-jcc/jjab030\"}, {\"title\": \"Intake of artificial sweeteners among adults is associated with reduced odds of gastrointestinal luminal cancers: a meta-analysis of cohort and case-control studies\", \"url\": \"https://experts.mcmaster.ca/display/publication2124126\", \"journal\": \"Progress in Food and Nutrition Science\", \"year\": \"2021\", \"doi\": \"10.1016/j.nutres.2021.07.007\"}, {\"title\": \"Medical Management Following Surgical Therapy in Inflammatory Bowel Disease: Evidence from Cochrane Reviews\", \"url\": \"https://experts.mcmaster.ca/display/publication1956936\", \"journal\": \"Inflammatory Bowel Diseases\", \"year\": \"2021\", \"doi\": \"10.1093/ibd/izaa350\"}, {\"title\": \"A Microsimulation Model to Determine the Cost-Effectiveness of Treat-to-Target Strategies for Crohn's Disease\", \"url\": \"https://experts.mcmaster.ca/display/publication2135020\", \"journal\": \"American Journal of Gastroenterology\", \"year\": \"2021\", \"doi\": \"10.14309/ajg.0000000000001263\"}, {\"title\": \"Association of ultra-processed food intake with risk of inflammatory bowel disease: prospective cohort study\", \"url\": \"https://experts.mcmaster.ca/display/publication2010132\", \"journal\": \"The BMJ\", \"year\": \"2021\", \"doi\": \"10.1136/bmj.n1554\"}, {\"title\": \"End of Induction Patient-reported Outcomes Predict Clinical Remission but Not Endoscopic Remission in Crohn\\u2019s Disease\", \"url\": \"https://experts.mcmaster.ca/display/publication1939302\", \"journal\": \"Journal of Crohn's and Colitis\", \"year\": \"2021\", \"doi\": \"10.1093/ecco-jcc/jjaa242\"}, {\"title\": \"Early life exposures and the risk of inflammatory bowel disease: Systematic review and meta-analyses\", \"url\": \"https://experts.mcmaster.ca/display/publication1971167\", \"journal\": \"EClinicalMedicine\", \"year\": \"2021\", \"doi\": \"10.1016/j.eclinm.2021.100884\"}, {\"title\": \"The impact of ustekinumab on extraintestinal manifestations of Crohn's disease: Apost hocanalysis of the UNITI studies\", \"url\": \"https://experts.mcmaster.ca/display/publication1978971\", \"journal\": \"United European Gastroenterology Journal\", \"year\": \"2021\", \"doi\": \"10.1002/ueg2.12094\"}, {\"title\": \"Body Mass Index Does Not Impact Clinical Efficacy of Ustekinumab in Crohn\\u2019s Disease: A Post Hoc Analysis of the IM-UNITI Trial\", \"url\": \"https://experts.mcmaster.ca/display/publication1923186\", \"journal\": \"Inflammatory Bowel Diseases\", \"year\": \"2021\", \"doi\": \"10.1093/ibd/izaa214\"}, {\"title\": \"Editorial: methotrexate in patients with Crohn's disease refractory to anti\\u2010TNF therapy\\u2014moving backwards yet forward?\", \"url\": \"https://experts.mcmaster.ca/display/publication1964782\", \"journal\": \"Alimentary Pharmacology and Therapeutics\", \"year\": \"2021\", \"doi\": \"10.1111/apt.16327\"}, {\"title\": \"Week 6 Calprotectin Best Predicts Likelihood of Long-term Endoscopic Healing in Crohn\\u2019s Disease: A Post-hoc Analysis of the UNITI/IM-UNITI Trials\", \"url\": \"https://experts.mcmaster.ca/display/publication1926543\", \"journal\": \"Journal of Crohn's and Colitis\", \"year\": \"2021\", \"doi\": \"10.1093/ecco-jcc/jjaa189\"}, {\"title\": \"Active Margins, Plexitis, and Granulomas Increase Postoperative Crohn\\u2019s Recurrence: Systematic Review and Meta-analysis\", \"url\": \"https://experts.mcmaster.ca/display/publication1923187\", \"journal\": \"Clinical Gastroenterology and Hepatology\", \"year\": \"2021\", \"doi\": \"10.1016/j.cgh.2020.08.014\"}, {\"title\": \"Effect of Concomitant Therapy With Steroids and Tumor Necrosis Factor Antagonists for Induction of Remission in Patients With Crohn\\u2019s Disease: A Systematic Review and Pooled Meta-analysis\", \"url\": \"https://experts.mcmaster.ca/display/publication1916862\", \"journal\": \"Clinical Gastroenterology and Hepatology\", \"year\": \"2021\", \"doi\": \"10.1016/j.cgh.2020.06.036\"}, {\"title\": \"Impact of Digital Health Monitoring in the Management of Inflammatory Bowel Disease\", \"url\": \"https://experts.mcmaster.ca/display/publication1956937\", \"journal\": \"Journal of Medical Systems\", \"year\": \"2021\", \"doi\": \"10.1007/s10916-021-01706-x\"}, {\"title\": \"Mode of Delivery Does Not Affect the Risk of Inflammatory Bowel Disease\", \"url\": \"https://experts.mcmaster.ca/display/publication1701189\", \"journal\": \"Digestive Diseases and Sciences\", \"year\": \"2021\", \"doi\": \"10.1007/s10620-020-06204-7\"}, {\"title\": \"Risk of Postoperative Infectious Complications From Medical Therapies in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis\", \"url\": \"https://experts.mcmaster.ca/display/publication1691591\", \"journal\": \"Inflammatory Bowel Diseases\", \"year\": \"2020\", \"doi\": \"10.1093/ibd/izaa020\"}, {\"title\": \"Risk of postoperative infectious complications from medical therapies in inflammatory bowel disease\", \"url\": \"https://experts.mcmaster.ca/display/publication1935984\", \"journal\": \"Cochrane Database of Systematic Reviews\", \"year\": \"2020\", \"doi\": \"10.1002/14651858.cd013256.pub2\"}, {\"title\": \"Ileal and Rectal Ulcer Size Affects the Ability to Achieve Endoscopic Remission: A Post hoc Analysis of the SONIC Trial\", \"url\": \"https://experts.mcmaster.ca/display/publication1920338\", \"journal\": \"American Journal of Gastroenterology\", \"year\": \"2020\", \"doi\": \"10.14309/ajg.0000000000000617\"}, {\"title\": \"Higher vedolizumab serum levels do not increase the risk of adverse events in patients with inflammatory bowel disease\", \"url\": \"https://experts.mcmaster.ca/display/publication1915916\", \"journal\": \"Scandinavian Journal of Gastroenterology\", \"year\": \"2020\", \"doi\": \"10.1080/00365521.2020.1780470\"}, {\"title\": \"Incorporating Fecal Calprotectin Into Clinical Practice for Patients With Moderate-to-Severely Active Ulcerative Colitis Treated With Biologics or Small-Molecule Inhibitors\", \"url\": \"https://experts.mcmaster.ca/display/publication1893561\", \"journal\": \"American Journal of Gastroenterology\", \"year\": \"2020\", \"doi\": \"10.14309/ajg.0000000000000596\"}, {\"title\": \"Letter: mesalazine\\u2014a safe drug with rare serious adverse events? Authors\\u2019 reply\", \"url\": \"https://experts.mcmaster.ca/display/publication1905884\", \"journal\": \"Alimentary Pharmacology and Therapeutics\", \"year\": \"2020\", \"doi\": \"10.1111/apt.15748\"}, {\"title\": \"Ulcerative Colitis Patients Continue to Improve Over the First Six Months of Vedolizumab Treatment: 12-Month Clinical and Mucosal Healing Effectiveness\", \"url\": \"https://experts.mcmaster.ca/display/publication1743441\", \"journal\": \"Journal of the Canadian Association of Gastroenterology\", \"year\": \"2020\", \"doi\": \"10.1093/jcag/gwy065\"}, {\"title\": \"Prevalence of endoscopic improvement and remission according to patient\\u2010reported outcomes in ulcerative colitis\", \"url\": \"https://experts.mcmaster.ca/display/publication1680386\", \"journal\": \"Alimentary Pharmacology and Therapeutics\", \"year\": \"2020\", \"doi\": \"10.1111/apt.15577\"}, {\"title\": \"Is Blood Urea Concentration an Independent Predictor of Positive Endoscopic Findings in Presumed Upper Gastrointestinal Bleeding?\", \"url\": \"https://experts.mcmaster.ca/display/publication1654095\", \"journal\": \"Digestive Diseases\", \"year\": \"2020\", \"doi\": \"10.1159/000501549\"}, {\"title\": \"Risk for development of inflammatory bowel disease under inhibition of interleukin 17: A systematic review and meta-analysis\", \"url\": \"https://experts.mcmaster.ca/display/publication1914162\", \"journal\": \"PLoS ONE\", \"year\": \"2020\", \"doi\": \"10.1371/journal.pone.0233781\"}, {\"title\": \"Association Between Helicobacter pylori Exposure and Decreased Odds of Eosinophilic Esophagitis\\u2014A Systematic Review and Meta-analysis\", \"url\": \"https://experts.mcmaster.ca/display/publication1620999\", \"journal\": \"Clinical Gastroenterology and Hepatology\", \"year\": \"2019\", \"doi\": \"10.1016/j.cgh.2019.01.013\"}, {\"title\": \"Response to Letter by Moulton et al.\", \"url\": \"https://experts.mcmaster.ca/display/publication1631396\", \"journal\": \"Inflammatory Bowel Diseases\", \"year\": \"2019\", \"doi\": \"10.1093/ibd/izz035\"}, {\"title\": \"Systematic review with meta\\u2010analysis: association betweenHelicobacter pyloriCagA seropositivity and odds of inflammatory bowel disease\", \"url\": \"https://experts.mcmaster.ca/display/publication1644604\", \"journal\": \"Alimentary Pharmacology and Therapeutics\", \"year\": \"2019\", \"doi\": \"10.1111/apt.15306\"}, {\"title\": \"Anxiety But Not Depression Predicts Poor Outcomes in Inflammatory Bowel Disease\", \"url\": \"https://experts.mcmaster.ca/display/publication1618926\", \"journal\": \"Inflammatory Bowel Diseases\", \"year\": \"2019\", \"doi\": \"10.1093/ibd/izy385\"}, {\"title\": \"Higher adalimumab serum levels do not increase the risk of adverse events in patients with inflammatory bowel disease\", \"url\": \"https://experts.mcmaster.ca/display/publication1643196\", \"journal\": \"Scandinavian Journal of Gastroenterology\", \"year\": \"2019\", \"doi\": \"10.1080/00365521.2019.1621367\"}, {\"title\": \"Correction: Vedolizumab for Ulcerative Colitis: Treatment Outcomes from the VICTORY Consortium\", \"url\": \"https://experts.mcmaster.ca/display/publication1607289\", \"journal\": \"American Journal of Gastroenterology\", \"year\": \"2019\", \"doi\": \"10.1038/s41395-018-0401-4\"}, {\"title\": \"Risk of postoperative infectious complications from medical therapies in inflammatory bowel disease\", \"url\": \"https://experts.mcmaster.ca/display/publication1747429\", \"journal\": \"Cochrane Database of Systematic Reviews\", \"year\": \"2019\", \"doi\": \"10.1002/14651858.cd013256\"}, {\"title\": \"Patient-Reported Outcomes and Endoscopic Appearance of Ulcerative Colitis: A Systematic Review and Meta-analysis\", \"url\": \"https://experts.mcmaster.ca/display/publication1553059\", \"journal\": \"Clinical Gastroenterology and Hepatology\", \"year\": \"2019\", \"doi\": \"10.1016/j.cgh.2018.06.015\"}, {\"title\": \"Impact of Adalimumab Patient Support Program\\u2019s Care Coach Calls on Clinical\\n          Outcomes in Patients with Crohn\\u2019s Disease in Canada: An Observational Retrospective Cohort\\n          Study\", \"url\": \"https://experts.mcmaster.ca/display/publication1652657\", \"journal\": \"Journal of the Canadian Association of Gastroenterology\", \"year\": \"2018\", \"doi\": \"10.1093/jcag/gwy059\"}, {\"title\": \"Development and Validation of a Scoring System to Predict Outcomes of Vedolizumab Treatment in Patients With Crohn\\u2019s\\u00a0Disease\", \"url\": \"https://experts.mcmaster.ca/display/publication1543144\", \"journal\": \"Gastroenterology\", \"year\": \"2018\", \"doi\": \"10.1053/j.gastro.2018.05.039\"}, {\"title\": \"Open: Vedolizumab for Ulcerative Colitis: Treatment Outcomes from the VICTORY Consortium\", \"url\": \"https://experts.mcmaster.ca/display/publication1561805\", \"journal\": \"American Journal of Gastroenterology\", \"year\": \"2018\", \"doi\": \"10.1038/s41395-018-0162-0\"}, {\"title\": \"Safety of Propofol versus Nonpropofol-Based Sedation in Children Undergoing Gastrointestinal Endoscopy: A Systematic Review and Meta-Analysis\", \"url\": \"https://experts.mcmaster.ca/display/publication1590343\", \"journal\": \"Gastroenterology Research and Practice\", \"year\": \"2018\", \"doi\": \"10.1155/2018/6501215\"}, {\"title\": \"The Role of Biomarkers in Clinical Trials of Inflammatory Bowel Disease\", \"url\": \"https://experts.mcmaster.ca/display/publication1543143\", \"journal\": \"Inflammatory Bowel Diseases\", \"year\": \"2018\", \"doi\": \"10.1093/ibd/izy195\"}, {\"title\": \"Systematic review: safety of mesalazine in ulcerative colitis\", \"url\": \"https://experts.mcmaster.ca/display/publication1524689\", \"journal\": \"Alimentary Pharmacology and Therapeutics\", \"year\": \"2018\", \"doi\": \"10.1111/apt.14688\"}, {\"title\": \"Role of endoscopy in inflammatory bowel disease\", \"url\": \"https://experts.mcmaster.ca/display/publication1543142\", \"journal\": \"Gastroenterology Report\", \"year\": \"2018\", \"doi\": \"10.1093/gastro/goy006\"}, {\"title\": \"Systematic Review and Meta-Analysis: Preoperative Vedolizumab Treatment and Postoperative Complications in Patients with Inflammatory Bowel Disease\", \"url\": \"https://experts.mcmaster.ca/display/publication1524692\", \"journal\": \"Journal of Crohn's and Colitis\", \"year\": \"2018\", \"doi\": \"10.1093/ecco-jcc/jjy022\"}, {\"title\": \"Enteral nutritional therapy for induction of remission in Crohn's disease\", \"url\": \"https://experts.mcmaster.ca/display/publication1514128\", \"journal\": \"Cochrane Database of Systematic Reviews\", \"year\": \"2018\", \"doi\": \"10.1002/14651858.cd000542.pub3\"}, {\"title\": \"Systematic Review and Meta-analysis\", \"url\": \"https://experts.mcmaster.ca/display/publication1458956\", \"journal\": \"Inflammatory Bowel Diseases\", \"year\": \"2017\", \"doi\": \"10.1097/mib.0000000000001228\"}, {\"title\": \"Systematic Review and Meta-analysis: Fecal Microbiota Transplantation for Treatment of Active Ulcerative Colitis.\", \"url\": \"https://experts.mcmaster.ca/display/publication1458955\", \"journal\": \"Inflammatory Bowel Diseases\", \"year\": \"2017\", \"doi\": \"10.1097/MIB.0000000000001228\"}, {\"title\": \"Systematic review with meta\\u2010analysis: proximal disease extension in limited ulcerative colitis\", \"url\": \"https://experts.mcmaster.ca/display/publication816946\", \"journal\": \"Alimentary Pharmacology and Therapeutics\", \"year\": \"2017\", \"doi\": \"10.1111/apt.14063\"}, {\"title\": \"Trends in Narcotic and Corticosteroid Prescriptions in Patients with Inflammatory Bowel Disease in the United States Ambulatory Care Setting from 2003 to 2011\", \"url\": \"https://experts.mcmaster.ca/display/publication816948\", \"journal\": \"Inflammatory Bowel Diseases\", \"year\": \"2017\", \"doi\": \"10.1097/mib.0000000000001084\"}, {\"title\": \"The morbidity and mortality of hepaticojejunostomies for complex bile duct injuries: a multi-institutional analysis of risk factors and outcomes using NSQIP\", \"url\": \"https://experts.mcmaster.ca/display/publication816961\", \"journal\": \"HPB\", \"year\": \"2017\", \"doi\": \"10.1016/j.hpb.2016.12.004\"}, {\"title\": \"Review article: dose optimisation of infliximab for acute severe ulcerative colitis\", \"url\": \"https://experts.mcmaster.ca/display/publication816967\", \"journal\": \"Alimentary Pharmacology and Therapeutics\", \"year\": \"2017\", \"doi\": \"10.1111/apt.13913\"}, {\"title\": \"Preventive care for a 35-year-old woman with inflammatory bowel disease\", \"url\": \"https://experts.mcmaster.ca/display/publication816957\", \"journal\": \"CANADIAN MEDICAL ASSOCIATION JOURNAL\", \"year\": \"2017\", \"doi\": \"10.1503/cmaj.160640\"}, {\"title\": \"Impact of High-Dose Vitamin D3 Supplementation in Patients with Crohn\\u2019s Disease in Remission: A Pilot Randomized Double-Blind Controlled Study\", \"url\": \"https://experts.mcmaster.ca/display/publication485208\", \"journal\": \"Digestive Diseases and Sciences\", \"year\": \"2017\", \"doi\": \"10.1007/s10620-016-4396-7\"}, {\"title\": \"Management Strategies to Improve Outcomes of Patients With Inflammatory Bowel Diseases\", \"url\": \"https://experts.mcmaster.ca/display/publication816986\", \"journal\": \"Gastroenterology\", \"year\": \"2017\", \"doi\": \"10.1053/j.gastro.2016.09.046\"}, {\"title\": \"Letter: comparative safety and efficacy of infliximab vs. adalimumab in Crohn's disease \\u2013 should one consider disease location? Authors\\u2019 reply\", \"url\": \"https://experts.mcmaster.ca/display/publication436492\", \"journal\": \"Alimentary Pharmacology and Therapeutics\", \"year\": \"2016\", \"doi\": \"10.1111/apt.13768\"}, {\"title\": \"Mucosal Healing Is Associated With Improved Long-term Outcomes of Patients With Ulcerative Colitis: A Systematic Review and Meta-analysis\", \"url\": \"https://experts.mcmaster.ca/display/publication817000\", \"journal\": \"Clinical Gastroenterology and Hepatology\", \"year\": \"2016\", \"doi\": \"10.1016/j.cgh.2016.01.015\"}, {\"title\": \"Reply\", \"url\": \"https://experts.mcmaster.ca/display/publication816996\", \"journal\": \"Clinical Gastroenterology and Hepatology\", \"year\": \"2016\", \"doi\": \"10.1016/j.cgh.2016.04.002\"}, {\"title\": \"The Real-World Effectiveness and Safety of Vedolizumab for Moderate\\u2013Severe Crohn\\u2019s Disease: Results From the US VICTORY Consortium\", \"url\": \"https://experts.mcmaster.ca/display/publication799726\", \"journal\": \"American Journal of Gastroenterology\", \"year\": \"2016\", \"doi\": \"10.1038/ajg.2016.236\"}, {\"title\": \"The efficacy and safety of either infliximab or adalimumab in 362 patients with anti\\u2010TNF\\u2010\\u03b1 na\\u00efve Crohn's disease\", \"url\": \"https://experts.mcmaster.ca/display/publication436500\", \"journal\": \"Alimentary Pharmacology and Therapeutics\", \"year\": \"2016\", \"doi\": \"10.1111/apt.13671\"}, {\"title\": \"Letter: mucosal healing is associated with improved long\\u2010term outcomes in Crohn's disease \\u2013 authors' reply\", \"url\": \"https://experts.mcmaster.ca/display/publication816992\", \"journal\": \"Alimentary Pharmacology and Therapeutics\", \"year\": \"2016\", \"doi\": \"10.1111/apt.13637\"}, {\"title\": \"Adverse Events During Anti-TNF\\u03b1 Therapies in IBD (Excluding Infections and Malignancies)\", \"url\": \"https://experts.mcmaster.ca/display/publication816998\", \"journal\": \"Inflammatory Bowel Diseases\", \"year\": \"2016\", \"doi\": \"10.1097/mib.0000000000000703\"}, {\"title\": \"Systematic Review and Meta-Analysis: Infliximab or Cyclosporine as Rescue Therapy in Patients With Severe Ulcerative Colitis Refractory to Steroids\", \"url\": \"https://experts.mcmaster.ca/display/publication436508\", \"journal\": \"American Journal of Gastroenterology\", \"year\": \"2016\", \"doi\": \"10.1038/ajg.2016.7\"}, {\"title\": \"Systematic review with meta\\u2010analysis: mucosal healing is associated with improved long\\u2010term outcomes in Crohn's disease\", \"url\": \"https://experts.mcmaster.ca/display/publication817003\", \"journal\": \"Alimentary Pharmacology and Therapeutics\", \"year\": \"2016\", \"doi\": \"10.1111/apt.13475\"}, {\"title\": \"When to perform gastroscopy in the PSC patient\", \"url\": \"https://experts.mcmaster.ca/display/publication817002\", \"journal\": \"Annals of Hepatology\", \"year\": \"2016\", \"doi\": \"10.5604/16652681.1184294\"}, {\"title\": \"Systematic Review\", \"url\": \"https://experts.mcmaster.ca/display/publication436558\", \"journal\": \"Inflammatory Bowel Diseases\", \"year\": \"2015\", \"doi\": \"10.1097/mib.0000000000000350\"}, {\"title\": \"Management of Severe Ulcerative Colitis\", \"url\": \"https://experts.mcmaster.ca/display/publication817019\", \"journal\": \"Current Treatment Options in Gastroenterology\", \"year\": \"2015\", \"doi\": \"10.1007/s11938-014-0036-5\"}, {\"title\": \"Anti-TNF\\u03b1 Therapies Are Safe During Pregnancy in Women with Inflammatory Bowel Disease\", \"url\": \"https://experts.mcmaster.ca/display/publication485256\", \"journal\": \"Inflammatory Bowel Diseases\", \"year\": \"2014\", \"doi\": \"10.1097/mib.0000000000000092\"}, {\"title\": \"Combination Therapy With Methotrexate in Inflammatory Bowel Disease: Time to COMMIT?\", \"url\": \"https://experts.mcmaster.ca/display/publication817040\", \"journal\": \"Gastroenterology\", \"year\": \"2014\", \"doi\": \"10.1053/j.gastro.2014.01.040\"}, {\"title\": \"Fecal Occult Blood Testing as a Diagnostic Test in Symptomatic Patients is not Useful: A Retrospective Chart Review\", \"url\": \"https://experts.mcmaster.ca/display/publication485246\", \"journal\": \"Canadian Journal of Gastroenterology and Hepatology\", \"year\": \"2014\", \"doi\": \"10.1155/2014/189652\"}, {\"title\": \"Does acetylsalicylic acid or warfarin affect the accuracy of fecal occult blood tests?\", \"url\": \"https://experts.mcmaster.ca/display/publication485339\", \"journal\": \"Journal of Gastroenterology and Hepatology\", \"year\": \"2013\", \"doi\": \"10.1111/jgh.12201\"}, {\"title\": \"Meta\\u2010analysis: peri\\u2010operative anti\\u2010TNF\\u03b1 treatment and post\\u2010operative complications in patients with inflammatory bowel disease\", \"url\": \"https://experts.mcmaster.ca/display/publication485365\", \"journal\": \"Alimentary Pharmacology and Therapeutics\", \"year\": \"2013\", \"doi\": \"10.1111/apt.12313\"}, {\"title\": \"Meta\\u2010analysis: colonoscopic post\\u2010polypectomy bleeding in patients on continued clopidogrel therapy\", \"url\": \"https://experts.mcmaster.ca/display/publication485357\", \"journal\": \"Alimentary Pharmacology and Therapeutics\", \"year\": \"2013\", \"doi\": \"10.1111/apt.12292\"}, {\"title\": \"An evaluation of the \\u20185 Minute Medicine\\u2019 video podcast series compared to conventional medical resources for the internal medicine clerkship\", \"url\": \"https://experts.mcmaster.ca/display/publication811997\", \"journal\": \"Medical Teacher\", \"year\": \"2012\", \"doi\": \"10.3109/0142159x.2012.689446\"}, {\"title\": \"Are Patients with Inflammatory Bowel Disease at Increased Risk of Coronary Artery Disease?\", \"url\": \"https://experts.mcmaster.ca/display/publication485371\", \"journal\": \"American Journal of Medicine\", \"year\": \"2012\", \"doi\": \"10.1016/j.amjmed.2012.03.015\"}, {\"title\": \"Management of inflammatory bowel disease with vitamin D: Beyond bone health\", \"url\": \"https://experts.mcmaster.ca/display/publication485367\", \"journal\": \"Journal of Crohn's and Colitis\", \"year\": \"2012\", \"doi\": \"10.1016/j.crohns.2011.10.015\"}, {\"title\": \"An Audit of Influenza Vaccination Status in Adults with Inflammatory Bowel Disease\", \"url\": \"https://experts.mcmaster.ca/display/publication485335\", \"journal\": \"Canadian Journal of Gastroenterology and Hepatology\", \"year\": \"2012\", \"doi\": \"10.1155/2012/158362\"}, {\"title\": \"Should Albumin Be Used in All Patients with Spontaneous Bacterial Peritonitis?\", \"url\": \"https://experts.mcmaster.ca/display/publication485433\", \"journal\": \"Canadian Journal of Gastroenterology and Hepatology\", \"year\": \"2011\", \"doi\": \"10.1155/2011/586702\"}, {\"title\": \"Role of probiotics in management of diverticular disease\", \"url\": \"https://experts.mcmaster.ca/display/publication485413\", \"journal\": \"Journal of Gastroenterology and Hepatology\", \"year\": \"2010\", \"doi\": \"10.1111/j.1440-1746.2010.06444.x\"}, {\"title\": \"IgG4-Related Sclerosing Disease: A Novel Mimic of Inflammatory Bowel Disease\", \"url\": \"https://experts.mcmaster.ca/display/publication485417\", \"journal\": \"Digestive Diseases and Sciences\", \"year\": \"2010\", \"doi\": \"10.1007/s10620-010-1287-1\"}, {\"title\": \"Should My Patient with Inflammatory Bowel Disease on Immunosuppressive Therapy be Vaccinated against Influenza Virus?\", \"url\": \"https://experts.mcmaster.ca/display/publication485472\", \"journal\": \"Canadian Journal of Gastroenterology and Hepatology\", \"year\": \"2010\", \"doi\": \"10.1155/2010/375878\"}, {\"title\": \"Does Smoking Reduce Infliximab\\u2019s Effectiveness against Crohn\\u2019s Disease?\", \"url\": \"https://experts.mcmaster.ca/display/publication817129\", \"journal\": \"Canadian Journal of Gastroenterology and Hepatology\", \"year\": \"2009\", \"doi\": \"10.1155/2009/431349\"}, {\"title\": \"Exercise and Inflammatory Bowel Disease\", \"url\": \"https://experts.mcmaster.ca/display/publication817141\", \"journal\": \"Canadian Journal of Gastroenterology and Hepatology\", \"year\": \"2008\", \"doi\": \"10.1155/2008/785953\"}], \"chapters\": [], \"conferences\": [{\"title\": \"Adaptive Steroid Tapering Impedes Corticosteroid-free Remissions Compared with Forced Tapering in Clinical Trials of Ulcerative Colitis\", \"url\": \"https://experts.mcmaster.ca/display/publication3414760\", \"journal\": \"Journal of Crohn's and Colitis\", \"year\": \"2024\", \"doi\": \"10.1093/ecco-jcc/jjae092\"}, {\"title\": \"Tofacitinib for hospitalized acute severe Ulcerative Colitis - the TRIUMPH study\", \"url\": \"https://experts.mcmaster.ca/display/publication3412884\", \"journal\": \"Crohn's and Colitis 360\", \"year\": \"2024\", \"doi\": \"10.1093/crocol/otaf013\"}, {\"title\": \"The Performance of the Rutgeerts Score, SES-CD, and MM-SES-CD for Prediction of Postoperative Clinical Recurrence in Crohn\\u2019s Disease\", \"url\": \"https://experts.mcmaster.ca/display/publication2187540\", \"journal\": \"Inflammatory Bowel Diseases\", \"year\": \"2023\", \"doi\": \"10.1093/ibd/izac130\"}, {\"title\": \"Comparative Effectiveness of Biologics for Endoscopic Healing of the Ileum and Colon in Crohn's Disease\", \"url\": \"https://experts.mcmaster.ca/display/publication2187537\", \"journal\": \"American Journal of Gastroenterology\", \"year\": \"2022\", \"doi\": \"10.14309/ajg.0000000000001795\"}, {\"title\": \"Histologic remission does not offer additional benefit for ulcerative colitis patients in endoscopic remission\", \"url\": \"https://experts.mcmaster.ca/display/publication1702655\", \"journal\": \"Alimentary Pharmacology and Therapeutics\", \"year\": \"2020\", \"doi\": \"10.1111/apt.16147\"}, {\"title\": \"WEEK 2 ADALIMUMAB LEVEL PREDICTS SHORT-TERM CLINICAL REMISSION IN PATIENTS WITH IBD\", \"url\": \"https://experts.mcmaster.ca/display/publication1644835\", \"journal\": \"Gastroenterology\", \"year\": \"2019\"}, {\"title\": \"Mode of delivery and risk of inflammatory bowel disease\", \"url\": \"https://experts.mcmaster.ca/display/publication1634546\", \"journal\": \"Journal of Crohn's and Colitis\", \"year\": \"2019\"}, {\"title\": \"Surveillance colonoscopies in ulcerative colitis: does it make a difference?\", \"url\": \"https://experts.mcmaster.ca/display/publication1634547\", \"journal\": \"Journal of Crohn's and Colitis\", \"year\": \"2019\"}, {\"title\": \"P607 Higher adalimumab serum levels do not increase the risk of adverse events in patients with inflammatory bowel disease\", \"url\": \"https://experts.mcmaster.ca/display/publication1634545\", \"journal\": \"Journal of Crohn's and Colitis\", \"year\": \"2019\", \"doi\": \"10.1093/ecco-jcc/jjy222.731\"}, {\"title\": \"Higher adalimumab maintenance regimens are more effective than standard maintenance doses in Crohn's disease patients who have failed infliximab\", \"url\": \"https://experts.mcmaster.ca/display/publication1518038\", \"journal\": \"Journal of Crohn's and Colitis\", \"year\": \"2018\"}, {\"title\": \"Pre-operative vedolizumab treatment and postoperative complications in patients with inflammatory bowel disease: A systematic review and meta-analysis\", \"url\": \"https://experts.mcmaster.ca/display/publication1518039\", \"journal\": \"Journal of Crohn's and Colitis\", \"year\": \"2018\"}, {\"title\": \"Systematic review and meta-analysis: Patient-reported outcomes and endoscopic appearance in ulcerative colitis\", \"url\": \"https://experts.mcmaster.ca/display/publication1515487\", \"journal\": \"Journal of Crohn's and Colitis\", \"year\": \"2018\"}, {\"title\": \"Higher Adalimumab Maintenance Regimens Are More Effective Than Standard Maintenance Regimens in Crohn\\u02bcs Disease Patients Who Have Failed Infliximab\", \"url\": \"https://experts.mcmaster.ca/display/publication1581199\", \"journal\": \"American Journal of Gastroenterology\", \"year\": \"2017\", \"doi\": \"10.14309/00000434-201710001-00745\"}, {\"title\": \"Systematic review with meta\\u2010analysis: enteral nutrition therapy for the induction of remission in paediatric Crohn's disease\", \"url\": \"https://experts.mcmaster.ca/display/publication1080333\", \"journal\": \"Alimentary Pharmacology and Therapeutics\", \"year\": \"2017\", \"doi\": \"10.1111/apt.14253\"}, {\"title\": \"Persistent Symptoms, CRP Elevation and Treatment Changes Over Time in Crohn's Disease Patients are Associated with Bowel Damage Progression as Expressed by Deterioration of Lemann Index Score\", \"url\": \"https://experts.mcmaster.ca/display/publication1333703\", \"journal\": \"Gastroenterology\", \"year\": \"2017\", \"doi\": \"10.1016/s0016-5085(17)32719-1\"}, {\"title\": \"Proximal Disease Extension in Limited Ulcerative Colitis: A Systematic Review and Meta-Analysis\", \"url\": \"https://experts.mcmaster.ca/display/publication1333708\", \"journal\": \"Gastroenterology\", \"year\": \"2017\", \"doi\": \"10.1016/s0016-5085(17)33309-7\"}, {\"title\": \"Ulcerative Colitis Patients on Vedolizumab Lacking Response at Induction Phase Continue to Improve Over the First 6 Months of Treatment\", \"url\": \"https://experts.mcmaster.ca/display/publication1333709\", \"journal\": \"Gastroenterology\", \"year\": \"2017\", \"doi\": \"10.1016/s0016-5085(17)31575-5\"}, {\"title\": \"C-reactive protein improvement after vedolizumab induction phase is associated with remission after 6 months of treatment in ulcerative colitis patients\", \"url\": \"https://experts.mcmaster.ca/display/publication1333745\", \"journal\": \"Journal of Crohn's and Colitis\", \"year\": \"2017\"}, {\"title\": \"Impact of adalimumab's patient support program on clinical outcomes in inflammatory bowel diseases: results from the COMPANION study\", \"url\": \"https://experts.mcmaster.ca/display/publication485172\", \"journal\": \"Journal of Crohn's and Colitis\", \"year\": \"2017\"}, {\"title\": \"Persistent symptoms, CRP elevation and treatment changes over time in Crohn's disease patients are associated with bowel damage progression as expressed by deterioration of Lemann Index score\", \"url\": \"https://experts.mcmaster.ca/display/publication1333736\", \"journal\": \"Journal of Crohn's and Colitis\", \"year\": \"2017\"}, {\"title\": \"Proximal Disease Extension in Limited Ulcerative Colitis: A Systematic Review and Meta-Analysis\", \"url\": \"https://experts.mcmaster.ca/display/publication1333734\", \"journal\": \"Inflammatory Bowel Diseases\", \"year\": \"2017\"}, {\"title\": \"Proximal disease extension in limited ulcerative colitis: a systematic review and meta-analysis\", \"url\": \"https://experts.mcmaster.ca/display/publication1333742\", \"journal\": \"Journal of Crohn's and Colitis\", \"year\": \"2017\"}, {\"title\": \"Trends in narcotic and corticosteroid prescriptions in patients with inflammatory bowel disease in the United States ambulatory care setting from 2003 to 2011\", \"url\": \"https://experts.mcmaster.ca/display/publication1333733\", \"journal\": \"Journal of Crohn's and Colitis\", \"year\": \"2017\"}, {\"title\": \"Ulcerative colitis patients on vedolizumab lacking response at induction phase continue to improve over the first 6 months of treatment\", \"url\": \"https://experts.mcmaster.ca/display/publication1333738\", \"journal\": \"Journal of Crohn's and Colitis\", \"year\": \"2017\"}, {\"title\": \"PUB006 Impact of the New WHO Classification of Thymic Tumors: Cross-Validation of the Prognostic Value in a Single Institution Cohort\", \"url\": \"https://experts.mcmaster.ca/display/publication1484036\", \"journal\": \"Journal of Thoracic Oncology\", \"year\": \"2017\", \"doi\": \"10.1016/j.jtho.2016.11.1976\"}, {\"title\": \"Prognostic Value of the New WHO Thymoma Classification: Single institution Cross Validation Study\", \"url\": \"https://experts.mcmaster.ca/display/publication1511865\", \"journal\": \"Journal of Thoracic Oncology\", \"year\": \"2016\", \"doi\": \"10.1016/j.jtho.2016.09.061\"}, {\"title\": \"Outcomes of Second- and Third-LineTumor Necrosis Factor-\\u00ce\\u00b1 Antagonists in Inflammatory Bowel Disease\", \"url\": \"https://experts.mcmaster.ca/display/publication1333728\", \"journal\": \"American Journal of Gastroenterology\", \"year\": \"2016\", \"doi\": \"10.14309/00000434-201610001-00985\"}, {\"title\": \"Rho Kinase Ezpression in Giant Cell Arteritis: Validating Perm Intensity Score As a Method of Increasing Sensitivity of Temporal Artery Biopsy\", \"url\": \"https://experts.mcmaster.ca/display/publication1489861\", \"journal\": \"Arthritis & Rheumatology\", \"year\": \"2016\"}, {\"title\": \"Sa1888 Efficacy and Predictors of Outcomes of Vedolizumab for Ulcerative Colitis in Clinical Practice\", \"url\": \"https://experts.mcmaster.ca/display/publication1320061\", \"journal\": \"Gastroenterology\", \"year\": \"2016\", \"doi\": \"10.1016/s0016-5085(16)31377-4\"}, {\"title\": \"Sa1889 Efficacy and Predictors of Outcomes of Vedolizumab for Crohn's Disease in Clinical Practice\", \"url\": \"https://experts.mcmaster.ca/display/publication1320068\", \"journal\": \"Gastroenterology\", \"year\": \"2016\", \"doi\": \"10.1016/s0016-5085(16)31378-6\"}, {\"title\": \"Tu1908 Safety of Vedolizumab in Inflammatory Bowel Disease in a Multi-Center Real World Consortium\", \"url\": \"https://experts.mcmaster.ca/display/publication1320067\", \"journal\": \"Gastroenterology\", \"year\": \"2016\", \"doi\": \"10.1016/s0016-5085(16)33301-7\"}, {\"title\": \"Impact of high-dose vitamin D3 supplementation in treatment of Crohn's disease in remission: a randomised double-blind controlled study\", \"url\": \"https://experts.mcmaster.ca/display/publication1333746\", \"journal\": \"Journal of Crohn's and Colitis\", \"year\": \"2016\"}, {\"title\": \"Mucosal Healing Is Associated with Improved Long-Term Outcomes in Crohn's Disease: A Systematic Review and Meta-analysis\", \"url\": \"https://experts.mcmaster.ca/display/publication1333731\", \"journal\": \"Inflammatory Bowel Diseases\", \"year\": \"2016\"}, {\"title\": \"Mucosal Healing Is Associated with Improved Long-Term Outcomes in Ulcerative Colitis: A Systematic Review and Meta-analysis\", \"url\": \"https://experts.mcmaster.ca/display/publication1333724\", \"journal\": \"Inflammatory Bowel Diseases\", \"year\": \"2016\"}, {\"title\": \"P-064\\u2003Impact of High Dose Vitamin D3 Supplementation in Treatment of Crohn\\u02bcs Disease in Remission\", \"url\": \"https://experts.mcmaster.ca/display/publication1333735\", \"journal\": \"Inflammatory Bowel Diseases\", \"year\": \"2016\", \"doi\": \"10.1097/01.mib.0000480168.31416.a6\"}, {\"title\": \"Mucosal Healing Is Associated With Improved Long-Term Outcomes in Ulcerative Colitis: A Systematic Review and Meta-analysis Presidential Poster\", \"url\": \"https://experts.mcmaster.ca/display/publication1333748\", \"journal\": \"American Journal of Gastroenterology\", \"year\": \"2015\", \"doi\": \"10.14309/00000434-201510001-01953\"}, {\"title\": \"Vedolizumab for Moderate to Severely Active Inflammatory Bowel Disease: A Multicenter U.S. Consortium\", \"url\": \"https://experts.mcmaster.ca/display/publication1333760\", \"journal\": \"American Journal of Gastroenterology\", \"year\": \"2015\", \"doi\": \"10.14309/00000434-201510001-01904\"}, {\"title\": \"Systematic Review and Meta-Analysis: Infliximab or Ciclosporin as Rescue Therapy in Patients with Severe Ulcerative Colitis Refractory to Steroids\", \"url\": \"https://experts.mcmaster.ca/display/publication932574\", \"journal\": \"Journal of Crohn's and Colitis\", \"year\": \"2015\"}, {\"title\": \"Infliximab or Cyclosporine as Rescue Therapy in Patients With Severe Ulcerative Colitis Refractory to Steroids: A Systematic Review and Meta-Analysis\", \"url\": \"https://experts.mcmaster.ca/display/publication932568\", \"journal\": \"American Journal of Gastroenterology\", \"year\": \"2014\", \"doi\": \"10.14309/00000434-201410002-01772\"}, {\"title\": \"Anti-TNF alpha Therapies Are Safe During Pregnancy in Women With Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis\", \"url\": \"https://experts.mcmaster.ca/display/publication485182\", \"journal\": \"Gastroenterology\", \"year\": \"2014\"}, {\"title\": \"DOP040 Anti-TNF-\\u03b1 therapies are safe during pregnancy in patients with inflammatory bowel disease: a meta-analysis\", \"url\": \"https://experts.mcmaster.ca/display/publication1333751\", \"journal\": \"Journal of Crohn's and Colitis\", \"year\": \"2014\", \"doi\": \"10.1016/s1873-9946(14)60065-9\"}, {\"title\": \"An Audit of Fecal Occult Blood Testing in Hospital Inpatients\", \"url\": \"https://experts.mcmaster.ca/display/publication610307\", \"journal\": \"American Journal of Gastroenterology\", \"year\": \"2013\", \"doi\": \"10.14309/00000434-201310001-01650\"}, {\"title\": \"Peri-operative Anti-TNF\\u03b1 Treatment and Post-operative Complications in Patients with Inflammatory Bowel Disease: A Systematic Review and Meta-analysis\", \"url\": \"https://experts.mcmaster.ca/display/publication1333777\", \"journal\": \"American Journal of Gastroenterology\", \"year\": \"2013\", \"doi\": \"10.14309/00000434-201310001-01824\"}], \"other\": [{\"title\": \"Interim Analysis of a Trial Evaluating the Utility of Non-Targeted Biopsies for Colorectal Neoplasia Detection in\\u00a0Inflammatory Bowel Disease\", \"url\": \"https://experts.mcmaster.ca/display/publication3445727\", \"journal\": \"Clinical Gastroenterology and Hepatology\", \"year\": \"2024\", \"doi\": \"10.1016/j.cgh.2023.12.007\"}], \"preprints\": []}",
  "teaching_activities_json": "[]",
  "teaching_courses_count": 0,
  "coauthor_network_url": "https://experts.mcmaster.ca/vis/author-network/narulan",
  "science_map_url": "https://experts.mcmaster.ca/vis/map-of-science/narulan",
  "profile_url": "https://experts.mcmaster.ca/individual/narulan",
  "scraped_date": "2025-07-27T15:11:22.861849",
  "csv_name": "Neeraj Narula",
  "csv_degree": "MD, MPH, FRCPC",
  "csv_university": "McMaster University",
  "csv_faculty": "Faculty of Health Sciences",
  "csv_department": "Department of Health Research Methods, Evidence, and Impact (HEI)",
  "csv_other_depts": NaN,
  "csv_position": "Associate Professor",
  "csv_full_time": true,
  "csv_faculty_type": NaN,
  "csv_adjunct": false,
  "csv_uni_email": "narulan@mcmaster.ca",
  "csv_other_email": "neeraj.narula@medportal.ca",
  "csv_website": NaN,
  "csv_misc": NaN,
  "csv_twitter": NaN,
  "csv_phone": NaN,
  "csv_fax": NaN,
  "csv_gscholar": NaN,
  "csv_scopus": NaN,
  "csv_wos": NaN,
  "csv_orcid": NaN,
  "csv_researchgate": NaN,
  "csv_academicedu": NaN,
  "csv_linkedin": NaN,
  "csv_mendely": NaN,
  "publications": {
    "journal_articles": [
      {
        "title": "Validation of the Modified Multiplier of SES-CD (MM-SES-CD) to Predict Endoscopic Healing in Crohn's Disease: A Post Hoc Analysis of the SEAVUE Trial.",
        "url": "https://experts.mcmaster.ca/display/publication3602012",
        "journal": "Inflammatory Bowel Diseases",
        "year": "2025",
        "doi": "10.1093/ibd/izaf137"
      },
      {
        "title": "Comparative Predictive Utility of MM-SES-CD and SES-CD for Week 52 Endoscopic Remission in the Ileum and Colon in Crohn's Disease.",
        "url": "https://experts.mcmaster.ca/display/publication3596640",
        "journal": "Inflammatory Bowel Diseases",
        "year": "2025",
        "doi": "10.1093/ibd/izaf124"
      },
      {
        "title": "Effectiveness and Safety of Advanced Combination Treatment in Patients With Refractory Inflammatory Bowel Disease or Concomitant Immune-Mediated Disease or Extraintestinal Manifestations: A Multicenter Canadian Study.",
        "url": "https://experts.mcmaster.ca/display/publication3591258",
        "journal": "American Journal of Gastroenterology",
        "year": "2025",
        "doi": "10.14309/ajg.0000000000003573"
      },
      {
        "title": "Comparative Efficacy of Biologics and Small Molecule Therapies in Improving Patient-Reported Outcomes in Ulcerative Colitis: Systematic Review and Network Meta-Analysis",
        "url": "https://experts.mcmaster.ca/display/publication3459078",
        "journal": "Inflammatory Bowel Diseases",
        "year": "2025",
        "doi": "10.1093/ibd/izae163"
      },
      {
        "title": "Definitions, diagnosis, and management of postoperative recurrence in Crohn's disease patients with permanent ileostomy-a systematic review and meta-analysis.",
        "url": "https://experts.mcmaster.ca/display/publication3554630",
        "journal": "Journal of Crohn's and Colitis",
        "year": "2025",
        "doi": "10.1093/ecco-jcc/jjaf041"
      },
      {
        "title": "Novel outcomes in inflammatory bowel disease.",
        "url": "https://experts.mcmaster.ca/display/publication3554829",
        "journal": "Journal of Crohn's and Colitis",
        "year": "2025",
        "doi": "10.1093/ecco-jcc/jjaf040"
      },
      {
        "title": "Use of Modified Multiplier of the Simple Endoscopic Score for Crohn's Disease Endoscopic Improvement Thresholds Enhances Effect Size Differentiation Between Adalimumab Versus Placebo: A Post Hoc Analysis of the EXTEND Trial.",
        "url": "https://experts.mcmaster.ca/display/publication3486406",
        "journal": "Journal of Crohn's and Colitis",
        "year": "2025",
        "doi": "10.1093/ecco-jcc/jjae171"
      },
      {
        "title": "Treat-to-target of endoscopic remission in patients with inflammatory bowel disease in symptomatic remission on advanced therapies (QUOTIENT): rationale, design and protocol for an open-label, multicentre, pragmatic, randomised controlled trial.",
        "url": "https://experts.mcmaster.ca/display/publication3562762",
        "journal": "BMJ Open Gastroenterology",
        "year": "2025",
        "doi": "10.1136/bmjgast-2024-001615"
      },
      {
        "title": "Outcomes of Patients With Prior Biologic Intolerance Are Better Than Those With Biologic Failure in Clinical Trials of Inflammatory Bowel Disease.",
        "url": "https://experts.mcmaster.ca/display/publication3472663",
        "journal": "Journal of Crohn's and Colitis",
        "year": "2025",
        "doi": "10.1093/ecco-jcc/jjae151"
      },
      {
        "title": "A Review of the Modified Multiplier of Simple Endoscopic Score for Crohn's Disease and How to Use It in Clinical Trials and Practice.",
        "url": "https://experts.mcmaster.ca/display/publication3545273",
        "journal": "American Journal of Gastroenterology",
        "year": "2025",
        "doi": "10.14309/ajg.0000000000003373"
      },
      {
        "title": "Placebo Rates in Crohn's Disease Randomized Clinical Trials: An Individual Patient Data Meta-Analysis.",
        "url": "https://experts.mcmaster.ca/display/publication3478275",
        "journal": "Gastroenterology",
        "year": "2025",
        "doi": "10.1053/j.gastro.2024.10.009"
      },
      {
        "title": "Improvement in serum eosinophilia is observed in clinical responders to ustekinumab but not adalimumab in inflammatory bowel disease.",
        "url": "https://experts.mcmaster.ca/display/publication3525394",
        "journal": "Journal of Crohn's and Colitis",
        "year": "2025",
        "doi": "10.1093/ecco-jcc/jjaf006"
      },
      {
        "title": "Tofacitinib for Hospitalized Acute Severe Ulcerative Colitis Management (The TRIUMPH Study).",
        "url": "https://experts.mcmaster.ca/display/publication3558304",
        "journal": "Crohn's and Colitis 360",
        "year": "2025",
        "doi": "10.1093/crocol/otaf013"
      },
      {
        "title": "Using Diet to Treat Inflammatory Bowel Disease: A Systematic Review",
        "url": "https://experts.mcmaster.ca/display/publication3452270",
        "journal": "American Journal of Gastroenterology",
        "year": "2025",
        "doi": "10.14309/ajg.0000000000002973"
      },
      {
        "title": "Acceptability, feasibility, and impact of the MyGut digital health platform in the monitoring and management of inflammatory bowel disease.",
        "url": "https://experts.mcmaster.ca/display/publication3504743",
        "journal": "Journal of the Canadian Association of Gastroenterology",
        "year": "2024",
        "doi": "10.1093/jcag/gwae029"
      },
      {
        "title": "Clinical Trial Design Considerations for Hospitalised Patients With Ulcerative Colitis Flares and Application to Study Hyperbaric Oxygen Therapy in the NIDDK HBOT-UC Consortium.",
        "url": "https://experts.mcmaster.ca/display/publication3480443",
        "journal": "Alimentary Pharmacology and Therapeutics",
        "year": "2024",
        "doi": "10.1111/apt.18326"
      },
      {
        "title": "Corrigendum to \"Differential efficacy of medical therapies for ulcerative colitis according to disease extent: patient-level analysis from multiple randomized controlled trials\" volume 72, 102621.",
        "url": "https://experts.mcmaster.ca/display/publication3494533",
        "journal": "EClinicalMedicine",
        "year": "2024",
        "doi": "10.1016/j.eclinm.2024.102980"
      },
      {
        "title": "Effectiveness of Ustekinumab for Patients With Moderate-to-Severe Ulcerative Colitis: A Multicenter Real-World Canadian Study.",
        "url": "https://experts.mcmaster.ca/display/publication3504742",
        "journal": "American Journal of Gastroenterology",
        "year": "2024",
        "doi": "10.14309/ajg.0000000000003212"
      },
      {
        "title": "Preliminary Results From a Multicenter, Randomized Trial Using Fecal Microbiota Transplantation to Induce Remission in Patients With Mild-to-Moderate Crohn's Disease.",
        "url": "https://experts.mcmaster.ca/display/publication3488203",
        "journal": "American Journal of Gastroenterology",
        "year": "2024",
        "doi": "10.14309/ajg.0000000000003196"
      },
      {
        "title": "Perspectives on the sustained engagement with digital health tools: protocol for a qualitative interview study among people living with Inflammatory Bowel Disease or irritable bowel syndrome.",
        "url": "https://experts.mcmaster.ca/display/publication3488435",
        "journal": "BMJ Open",
        "year": "2024",
        "doi": "10.1136/bmjopen-2024-089220"
      },
      {
        "title": "Characteristics of Interventional Trials for Patients Living With Intestinal Stoma Registered in ClinicalTrials.gov With a Focus on Inflammatory Bowel Disease",
        "url": "https://experts.mcmaster.ca/display/publication3384673",
        "journal": "Inflammatory Bowel Diseases",
        "year": "2024",
        "doi": "10.1093/ibd/izad293"
      },
      {
        "title": "Interventions for Adjunctive Care in Patients With Inflammatory Bowel Disease and Permanent Ileostomy: A Systematic Review.",
        "url": "https://experts.mcmaster.ca/display/publication3479873",
        "journal": "Crohn's and Colitis 360",
        "year": "2024",
        "doi": "10.1093/crocol/otae056"
      },
      {
        "title": "Management of complications in patients with an ileostomy: an umbrella review of systematic reviews for the EndOTrial Consortium.",
        "url": "https://experts.mcmaster.ca/display/publication3472532",
        "journal": "International Journal of Colorectal Disease",
        "year": "2024",
        "doi": "10.1007/s00384-024-04714-8"
      },
      {
        "title": "Defining Endoscopic Remission in Crohn’s Disease: MM-SES-CD and SES-CD Thresholds Associated With Low Risk of Disease Progression",
        "url": "https://experts.mcmaster.ca/display/publication3403343",
        "journal": "Clinical Gastroenterology and Hepatology",
        "year": "2024",
        "doi": "10.1016/j.cgh.2024.02.009"
      },
      {
        "title": "Early Biologic Treatment Decreases Risk of Surgery in Crohn’s Disease but not in Ulcerative Colitis: Systematic Review and Meta-Analysis",
        "url": "https://experts.mcmaster.ca/display/publication3276973",
        "journal": "Inflammatory Bowel Diseases",
        "year": "2024",
        "doi": "10.1093/ibd/izad149"
      },
      {
        "title": "Delayed Ustekinumab and Adalimumab Responders Have Similar Outcomes as Early Responders in Biologic-Naïve Crohn's Disease",
        "url": "https://experts.mcmaster.ca/display/publication3389726",
        "journal": "American Journal of Gastroenterology",
        "year": "2024",
        "doi": "10.14309/ajg.0000000000002654"
      },
      {
        "title": "Comparative Efficacy of Advanced Therapies for Achieving Endoscopic Outcomes in Crohn’s Disease: A Systematic Review and Network Meta-Analysis",
        "url": "https://experts.mcmaster.ca/display/publication3386633",
        "journal": "Clinical Gastroenterology and Hepatology",
        "year": "2024",
        "doi": "10.1016/j.cgh.2023.12.023"
      },
      {
        "title": "Comparing the efficacy of vedolizumab between males and females: a post-hoc analysis of GEMINI-1 and VARSITY",
        "url": "https://experts.mcmaster.ca/display/publication3409104",
        "journal": "European Journal of Gastroenterology and Hepatology",
        "year": "2024",
        "doi": "10.1097/meg.0000000000002759"
      },
      {
        "title": "Differential efficacy of medical therapies for ulcerative colitis according to disease extent: patient-level analysis from multiple randomized controlled trials",
        "url": "https://experts.mcmaster.ca/display/publication3427026",
        "journal": "EClinicalMedicine",
        "year": "2024",
        "doi": "10.1016/j.eclinm.2024.102621"
      },
      {
        "title": "Resolution of rectal bleeding by day 7 in acute severe ulcerative colitis is prognostic for post-discharge corticosteroid free clinical remission and endoscopic improvement",
        "url": "https://experts.mcmaster.ca/display/publication3431652",
        "journal": "American Journal of Gastroenterology",
        "year": "2024",
        "doi": "10.14309/ajg.0000000000002860"
      },
      {
        "title": "Healthcare resource utilization following ustekinumab initiation among bio-naïve Canadian patients with moderately-to-severely active Crohn's disease",
        "url": "https://experts.mcmaster.ca/display/publication3437413",
        "journal": "Digestive and Liver Disease",
        "year": "2024",
        "doi": "10.1016/j.dld.2024.04.017"
      },
      {
        "title": "Pharmacological Therapies for the Management of Fistulizing Crohn’s Disease: A Systematic Review and Meta-Analysis",
        "url": "https://experts.mcmaster.ca/display/publication3307352",
        "journal": "Journal of Crohn's and Colitis",
        "year": "2024",
        "doi": "10.1093/ecco-jcc/jjad185"
      },
      {
        "title": "Endoscopic and Histological Placebo Rates in Crohn’s Disease Clinical Trials: A Systematic Review and Meta-analysis",
        "url": "https://experts.mcmaster.ca/display/publication3010261",
        "journal": "Inflammatory Bowel Diseases",
        "year": "2024",
        "doi": "10.1093/ibd/izad052"
      },
      {
        "title": "Integrating Evidence to Guide Use of Biologics and Small Molecules for Inflammatory Bowel Diseases",
        "url": "https://experts.mcmaster.ca/display/publication3309164",
        "journal": "Gastroenterology",
        "year": "2024",
        "doi": "10.1053/j.gastro.2023.10.033"
      },
      {
        "title": "Predicting Endoscopic Improvement in Ulcerative Colitis Using the Ulcerative Colitis Severity Index",
        "url": "https://experts.mcmaster.ca/display/publication3190786",
        "journal": "Inflammatory Bowel Diseases",
        "year": "2024",
        "doi": "10.1093/ibd/izad074"
      },
      {
        "title": "Matching-adjusted Indirect Comparisons vs Propensity Score Matching with Individual Patient-level Data to Estimate Treatment Efficacy",
        "url": "https://experts.mcmaster.ca/display/publication3242731",
        "journal": "Inflammatory Bowel Diseases",
        "year": "2024",
        "doi": "10.1093/ibd/izad077"
      },
      {
        "title": "Histological Remission Placebo Rates in Ulcerative Colitis Trials: A Systematic Review and Meta-analysis",
        "url": "https://experts.mcmaster.ca/display/publication2922723",
        "journal": "Inflammatory Bowel Diseases",
        "year": "2024",
        "doi": "10.1093/ibd/izad013"
      },
      {
        "title": "Editorial: Moving towards prognostic endoscopic scoring in IBD",
        "url": "https://experts.mcmaster.ca/display/publication3324567",
        "journal": "Alimentary Pharmacology and Therapeutics",
        "year": "2024",
        "doi": "10.1111/apt.17787"
      },
      {
        "title": "Patient Experience with the SensoReady® Autoinjector Pen versus a Comparator Device: Results from a Canadian Patient Survey in Rheumatoid Arthritis and Crohn´s Disease",
        "url": "https://experts.mcmaster.ca/display/publication3441719",
        "journal": "Patient Preference and Adherence",
        "year": "2024",
        "doi": "10.2147/ppa.s455791"
      },
      {
        "title": "Real-world effectiveness and safety of ustekinumab in bio-naive patients with moderate-to-severe Crohn's disease: A Canadian multi-center study",
        "url": "https://experts.mcmaster.ca/display/publication3294107",
        "journal": "Digestive and Liver Disease",
        "year": "2024",
        "doi": "10.1016/j.dld.2023.08.042"
      },
      {
        "title": "Delayed Ustekinumab Responders in Ulcerative Colitis Have Greater Inflammatory Burden but Similar Outcomes as Early Responders",
        "url": "https://experts.mcmaster.ca/display/publication3258356",
        "journal": "Clinical Gastroenterology and Hepatology",
        "year": "2023",
        "doi": "10.1016/j.cgh.2023.06.011"
      },
      {
        "title": "Efficacy and Safety of Advanced Oral Small Molecules for Inflammatory Bowel Disease: Systematic Review and Meta-Analysis",
        "url": "https://experts.mcmaster.ca/display/publication3251431",
        "journal": "Journal of Crohn's and Colitis",
        "year": "2023",
        "doi": "10.1093/ecco-jcc/jjad100"
      },
      {
        "title": "Baseline Patient-reported Symptoms Less Predictive Than MM-SES-CD for Endoscopic Remission in Crohn’s Disease",
        "url": "https://experts.mcmaster.ca/display/publication3242733",
        "journal": "Journal of Clinical Gastroenterology",
        "year": "2023",
        "doi": "10.1097/mcg.0000000000001774"
      },
      {
        "title": "Predictors of histologic response to mepolizumab in pediatric eosinophilic esophagitis",
        "url": "https://experts.mcmaster.ca/display/publication3281920",
        "journal": "European Journal of Gastroenterology and Hepatology",
        "year": "2023",
        "doi": "10.1097/meg.0000000000002623"
      },
      {
        "title": "Systematic review with meta‐analysis: Medical therapies for treatment of ulcerative proctitis",
        "url": "https://experts.mcmaster.ca/display/publication3281919",
        "journal": "Alimentary Pharmacology and Therapeutics",
        "year": "2023",
        "doi": "10.1111/apt.17666"
      },
      {
        "title": "The current role of Tofacitinib in acute severe ulcerative colitis in adult patients: A systematic review",
        "url": "https://experts.mcmaster.ca/display/publication3253726",
        "journal": "Digestive and Liver Disease",
        "year": "2023",
        "doi": "10.1016/j.dld.2023.05.021"
      },
      {
        "title": "Associations of Antibiotics, Hormonal Therapies, Oral Contraceptives, and Long-Term NSAIDS With Inflammatory Bowel Disease: Results From the Prospective Urban Rural Epidemiology (PURE) Study",
        "url": "https://experts.mcmaster.ca/display/publication2951618",
        "journal": "Clinical Gastroenterology and Hepatology",
        "year": "2023",
        "doi": "10.1016/j.cgh.2022.11.037"
      },
      {
        "title": "Efficacy and Safety of IL-12/23 and IL-23 Inhibitors for Crohn’s Disease: Systematic Review and Meta-Analysis",
        "url": "https://experts.mcmaster.ca/display/publication3255545",
        "journal": "Digestive Diseases and Sciences",
        "year": "2023",
        "doi": "10.1007/s10620-023-08014-z"
      },
      {
        "title": "Food Processing and Risk of Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis",
        "url": "https://experts.mcmaster.ca/display/publication3068329",
        "journal": "Clinical Gastroenterology and Hepatology",
        "year": "2023",
        "doi": "10.1016/j.cgh.2023.01.012"
      },
      {
        "title": "Predictors of Clinical Remission to Placebo in Clinical Trials of Crohn’s Disease",
        "url": "https://experts.mcmaster.ca/display/publication2579479",
        "journal": "Inflammatory Bowel Diseases",
        "year": "2023",
        "doi": "10.1093/ibd/izac231"
      },
      {
        "title": "Vedolizumab does not increase risk of clostridium difficile infection in patients with inflammatory bowel disease using vedolizumab: A retrospective cohort study",
        "url": "https://experts.mcmaster.ca/display/publication3284392",
        "journal": "Saudi Pharmaceutical Journal",
        "year": "2023",
        "doi": "10.1016/j.jsps.2023.101736"
      },
      {
        "title": "Ulcer Size After Induction Therapy Performs Better Than Symptom Assessment for Prediction of One Year Endoscopic Remission in Crohn’s Disease: A Post Hoc Analysis",
        "url": "https://experts.mcmaster.ca/display/publication2435761",
        "journal": "Inflammatory Bowel Diseases",
        "year": "2023",
        "doi": "10.1093/ibd/izac210"
      },
      {
        "title": "Combined Histological and Endoscopic Endpoints at Post-induction Lack Additional Prognostic Value Compared with Endoscopic Improvement Alone in Ulcerative Colitis: A Post hoc Analysis of the VARSITY study",
        "url": "https://experts.mcmaster.ca/display/publication2864764",
        "journal": "Journal of Crohn's and Colitis",
        "year": "2023",
        "doi": "10.1093/ecco-jcc/jjad033"
      },
      {
        "title": "Comparative Efficacy of Infliximab vs Ustekinumab for Maintenance of Clinical Response in Biologic Naïve Crohn’s Disease",
        "url": "https://experts.mcmaster.ca/display/publication2423411",
        "journal": "Inflammatory Bowel Diseases",
        "year": "2023",
        "doi": "10.1093/ibd/izac168"
      },
      {
        "title": "Declining Enrolment and Other Challenges in IBD Clinical Trials: Causes and Potential Solutions",
        "url": "https://experts.mcmaster.ca/display/publication2864765",
        "journal": "Journal of Crohn's and Colitis",
        "year": "2023",
        "doi": "10.1093/ecco-jcc/jjad020"
      },
      {
        "title": "Patients With Crohn's Disease and Permanent Ileostomy Are Universally Excluded From Clinical Trials: A Systematic Review",
        "url": "https://experts.mcmaster.ca/display/publication2835522",
        "journal": "American Journal of Gastroenterology",
        "year": "2023",
        "doi": "10.14309/ajg.0000000000002215"
      },
      {
        "title": "Comparative Efficacy of Infliximab Versus Tofacitinib for Inducing Remission in Biologic Naive Ulcerative Colitis: A Propensity Matched Study",
        "url": "https://experts.mcmaster.ca/display/publication3127668",
        "journal": "Digestive Diseases and Sciences",
        "year": "2023",
        "doi": "10.1007/s10620-023-07956-8"
      },
      {
        "title": "Increased Expression of Interleukin-13 Receptor in Ileum Associated With Nonresponse to Adalimumab in Ileal Crohn’s Disease",
        "url": "https://experts.mcmaster.ca/display/publication2421127",
        "journal": "Inflammatory Bowel Diseases",
        "year": "2023",
        "doi": "10.1093/ibd/izac157"
      },
      {
        "title": "Vedolizumab and Adalimumab in Biologic-Naïve Ulcerative Colitis: Comparison of Patient-Level Clinical Trial Data and VARSITY for Week 6 Clinical Remission",
        "url": "https://experts.mcmaster.ca/display/publication2746201",
        "journal": "Digestive Diseases and Sciences",
        "year": "2023",
        "doi": "10.1007/s10620-023-07825-4"
      },
      {
        "title": "REMIT-UC: Real-World Effectiveness and Safety of Tofacitinib for Moderate-to-Severely Active Ulcerative Colitis",
        "url": "https://experts.mcmaster.ca/display/publication3239421",
        "journal": "American Journal of Gastroenterology",
        "year": "2023",
        "doi": "10.14309/ajg.0000000000002129"
      },
      {
        "title": "Placebo Response Rates in Randomized Controlled Trials for Perianal Crohn’s Disease: A Systematic Review and Meta-Analysis",
        "url": "https://experts.mcmaster.ca/display/publication2553186",
        "journal": "Journal of Crohn's and Colitis",
        "year": "2023",
        "doi": "10.1093/ecco-jcc/jjac160"
      },
      {
        "title": "Beyond the White Pill: Advocating for Racial Diversity in IBD Trials",
        "url": "https://experts.mcmaster.ca/display/publication2429670",
        "journal": "Journal of Crohn's and Colitis",
        "year": "2023",
        "doi": "10.1093/ecco-jcc/jjac134"
      },
      {
        "title": "Most Placebo-Controlled Trials in Inflammatory Bowel Disease were Underpowered Because of Overestimated Drug Efficacy Rates: Results from a Systematic Review of Induction Studies",
        "url": "https://experts.mcmaster.ca/display/publication2435770",
        "journal": "Journal of Crohn's and Colitis",
        "year": "2023",
        "doi": "10.1093/ecco-jcc/jjac150"
      },
      {
        "title": "Correspondence on “PICaSSO Histologic Remission Index (PHRI) in ulcerative colitis: development of a novel simplified histological score for monitoring mucosal healing and predicting clinical outcomes and its applicability in an artificial intelligence system” by Guiet al",
        "url": "https://experts.mcmaster.ca/display/publication2232253",
        "journal": "Gut",
        "year": "2023",
        "doi": "10.1136/gutjnl-2022-327661"
      },
      {
        "title": "Predictors of Placebo Induction Response and Remission in Ulcerative Colitis",
        "url": "https://experts.mcmaster.ca/display/publication2473035",
        "journal": "Clinical Gastroenterology and Hepatology",
        "year": "2023",
        "doi": "10.1016/j.cgh.2022.08.015"
      },
      {
        "title": "Time to Endorse A Sensitive Method for Scoring Endoscopic Activity of Ulcerative Colitis in Clinical Research",
        "url": "https://experts.mcmaster.ca/display/publication2429671",
        "journal": "Journal of Crohn's and Colitis",
        "year": "2023",
        "doi": "10.1093/ecco-jcc/jjac120"
      },
      {
        "title": "Clinical remission in paired phase two and three studies in inflammatory bowel disease: a systematic review with meta-analysis",
        "url": "https://experts.mcmaster.ca/display/publication2777572",
        "journal": "European Journal of Gastroenterology and Hepatology",
        "year": "2023",
        "doi": "10.1097/meg.0000000000002490"
      },
      {
        "title": "Comparison of the Relative Sensitivity of Clinical, Endoscopic, and Histologic Remission for Detection of Treatment Efficacy in Ulcerative Colitis Trials",
        "url": "https://experts.mcmaster.ca/display/publication2315339",
        "journal": "Inflammatory Bowel Diseases",
        "year": "2023",
        "doi": "10.1093/ibd/izac128"
      },
      {
        "title": "The Real-World Effectiveness and Safety of Ustekinumab in the Treatment of Crohn's Disease: Results From the SUCCESS Consortium",
        "url": "https://experts.mcmaster.ca/display/publication2835262",
        "journal": "American Journal of Gastroenterology",
        "year": "2023",
        "doi": "10.14309/ajg.0000000000002047"
      },
      {
        "title": "The impact of clinical experience on decision-making regarding the treatment and management of mild-to-moderate ulcerative colitis",
        "url": "https://experts.mcmaster.ca/display/publication3068328",
        "journal": "Intestinal Research",
        "year": "2023",
        "doi": "10.5217/ir.2022.00006"
      },
      {
        "title": "Placebo Rates in Randomized Controlled Trials of Proctitis Therapy: A Systematic Review and Meta-Analysis Placebo Response in Proctitis",
        "url": "https://experts.mcmaster.ca/display/publication2429655",
        "journal": "Journal of Crohn's and Colitis",
        "year": "2023",
        "doi": "10.1093/ecco-jcc/jjac109"
      },
      {
        "title": "End of induction patient reported outcomes predict clinical remission and endoscopic improvement with vedolizumab and adalimumab in ulcerative colitis",
        "url": "https://experts.mcmaster.ca/display/publication2421125",
        "journal": "Scandinavian Journal of Gastroenterology",
        "year": "2023",
        "doi": "10.1080/00365521.2022.2105169"
      },
      {
        "title": "Long-Term Outcomes of Early vs Delayed Responders to Vedolizumab and Adalimumab: A Post Hoc Analysis of the VARSITY Study",
        "url": "https://experts.mcmaster.ca/display/publication2429672",
        "journal": "American Journal of Gastroenterology",
        "year": "2023",
        "doi": "10.14309/ajg.0000000000001987"
      },
      {
        "title": "Pilot study of an elimination diet in adults with mild to moderate Crohn’s disease",
        "url": "https://experts.mcmaster.ca/display/publication2472497",
        "journal": "European Journal of Gastroenterology and Hepatology",
        "year": "2022",
        "doi": "10.1097/meg.0000000000002438"
      },
      {
        "title": "Effectiveness of Tofacitinib for Hospitalized Patients with Acute Severe Ulcerative Colitis: Case Series",
        "url": "https://experts.mcmaster.ca/display/publication2173066",
        "journal": "Digestive Diseases and Sciences",
        "year": "2022",
        "doi": "10.1007/s10620-022-07439-2"
      },
      {
        "title": "Decision Support Tool Identifies Ulcerative Colitis Patients Most Likely to Achieve Remission With Vedolizumab vs Adalimumab",
        "url": "https://experts.mcmaster.ca/display/publication2157222",
        "journal": "Inflammatory Bowel Diseases",
        "year": "2022",
        "doi": "10.1093/ibd/izab310"
      },
      {
        "title": "Case Report: Managing Postoperative Crohn's Disease.",
        "url": "https://experts.mcmaster.ca/display/publication2445203",
        "journal": "Gastroenterology and Hepatology",
        "year": "2022"
      },
      {
        "title": "Week 2 Adalimumab Levels Predict Short-term Clinical Remission in Patients With Inflammatory Bowel Disease",
        "url": "https://experts.mcmaster.ca/display/publication2152104",
        "journal": "Journal of Clinical Gastroenterology",
        "year": "2022",
        "doi": "10.1097/mcg.0000000000001636"
      },
      {
        "title": "Categorising Endoscopic Severity of Crohn’s Disease Using the Modified Multiplier SES-CD [MM-SES-CD]",
        "url": "https://experts.mcmaster.ca/display/publication2167612",
        "journal": "Journal of Crohn's and Colitis",
        "year": "2022",
        "doi": "10.1093/ecco-jcc/jjac018"
      },
      {
        "title": "Comparative Efficacy and Rapidity of Action for Infliximab vs Ustekinumab in Biologic Naïve Crohn’s Disease",
        "url": "https://experts.mcmaster.ca/display/publication1966171",
        "journal": "Clinical Gastroenterology and Hepatology",
        "year": "2022",
        "doi": "10.1016/j.cgh.2021.04.006"
      },
      {
        "title": "Comparative Efficacy for Infliximab Vs Vedolizumab in Biologic Naive Ulcerative Colitis",
        "url": "https://experts.mcmaster.ca/display/publication2152404",
        "journal": "Clinical Gastroenterology and Hepatology",
        "year": "2022",
        "doi": "10.1016/j.cgh.2021.07.038"
      },
      {
        "title": "Predicting endoscopic remission in Crohn’s disease by the modified multiplier SES-CD (MM-SES-CD)",
        "url": "https://experts.mcmaster.ca/display/publication1964783",
        "journal": "Gut",
        "year": "2022",
        "doi": "10.1136/gutjnl-2020-323799"
      },
      {
        "title": "Reply",
        "url": "https://experts.mcmaster.ca/display/publication2189441",
        "journal": "Clinical Gastroenterology and Hepatology",
        "year": "2022",
        "doi": "10.1016/j.cgh.2021.08.024"
      },
      {
        "title": "Ustekinumab does not increase risk of new or recurrent cancer in inflammatory bowel disease patients with prior malignancy",
        "url": "https://experts.mcmaster.ca/display/publication2176323",
        "journal": "Journal of Gastroenterology and Hepatology",
        "year": "2022",
        "doi": "10.1111/jgh.15806"
      },
      {
        "title": "Early Reduction in MM-SES-CD Score After Initiation of Biologic Therapy is Highly Specific for 1-year Endoscopic Remission in Moderate to Severe Crohn’s Disease",
        "url": "https://experts.mcmaster.ca/display/publication2157223",
        "journal": "Journal of Crohn's and Colitis",
        "year": "2022",
        "doi": "10.1093/ecco-jcc/jjab183"
      },
      {
        "title": "Clinical Decision Support Tool for Infliximab in Crohn’s Disease",
        "url": "https://experts.mcmaster.ca/display/publication1986949",
        "journal": "Clinical Gastroenterology and Hepatology",
        "year": "2022",
        "doi": "10.1016/j.cgh.2021.06.037"
      },
      {
        "title": "Early Change in Epithelial Neutrophilic Infiltrate Predicts Long-Term Response to Biologics in Ulcerative Colitis",
        "url": "https://experts.mcmaster.ca/display/publication1986950",
        "journal": "Clinical Gastroenterology and Hepatology",
        "year": "2022",
        "doi": "10.1016/j.cgh.2021.07.005"
      },
      {
        "title": "Periodic Colonoscopies Are Associated with Improved Survival and Prognosis of Colorectal Cancer in Ulcerative Colitis",
        "url": "https://experts.mcmaster.ca/display/publication2048244",
        "journal": "Digestive Diseases and Sciences",
        "year": "2022",
        "doi": "10.1007/s10620-021-07151-7"
      },
      {
        "title": "Reply",
        "url": "https://experts.mcmaster.ca/display/publication1970900",
        "journal": "Clinical Gastroenterology and Hepatology",
        "year": "2022",
        "doi": "10.1016/j.cgh.2021.05.051"
      },
      {
        "title": "Resolution of dominant patient‐reported outcome at end of induction predicts clinical and endoscopic remission in Crohn’s disease",
        "url": "https://experts.mcmaster.ca/display/publication2167611",
        "journal": "Alimentary Pharmacology and Therapeutics",
        "year": "2022",
        "doi": "10.1111/apt.16805"
      },
      {
        "title": "Multinational evaluation of clinical decision-making in the treatment and management of mild-to-moderate ulcerative colitis",
        "url": "https://experts.mcmaster.ca/display/publication2157229",
        "journal": "Scandinavian Journal of Gastroenterology",
        "year": "2022",
        "doi": "10.1080/00365521.2021.2015801"
      },
      {
        "title": "Editorial: is it not justPROs, but the most important individualPRO, that really matters in Crohn’s disease? Authors’ reply",
        "url": "https://experts.mcmaster.ca/display/publication2182415",
        "journal": "Alimentary Pharmacology and Therapeutics",
        "year": "2022",
        "doi": "10.1111/apt.16866"
      },
      {
        "title": "Modelling the benefits of an optimised treatment strategy for 5-ASA in mild-to-moderate ulcerative colitis",
        "url": "https://experts.mcmaster.ca/display/publication2173067",
        "journal": "BMJ Open Gastroenterology",
        "year": "2022",
        "doi": "10.1136/bmjgast-2021-000853"
      },
      {
        "title": "Host Genetic Determinants Associated With Helicobacter pylori Eradication Treatment Failure: A Systematic Review and Meta-analysis",
        "url": "https://experts.mcmaster.ca/display/publication2137006",
        "journal": "Gastroenterology",
        "year": "2021",
        "doi": "10.1053/j.gastro.2021.07.043"
      },
      {
        "title": "Outcomes of Passable and Non-passable Strictures in Clinical Trials of Crohn’s Disease: A Post-hoc Analysis",
        "url": "https://experts.mcmaster.ca/display/publication1961799",
        "journal": "Journal of Crohn's and Colitis",
        "year": "2021",
        "doi": "10.1093/ecco-jcc/jjab045"
      },
      {
        "title": "Declining Use of Corticosteroids for Crohn’s Disease Has Implications for Study Recruitment: Results of a Pilot Randomized Controlled Trial",
        "url": "https://experts.mcmaster.ca/display/publication2132392",
        "journal": "Journal of the Canadian Association of Gastroenterology",
        "year": "2021",
        "doi": "10.1093/jcag/gwaa037"
      },
      {
        "title": "Comparative effectiveness of higher adalimumab maintenance therapyversusstandard dose in anti‐tumor necrosis factor experienced Crohn's disease patients: A propensity‐score matched cohort analysis",
        "url": "https://experts.mcmaster.ca/display/publication1970011",
        "journal": "Journal of Gastroenterology and Hepatology",
        "year": "2021",
        "doi": "10.1111/jgh.15551"
      },
      {
        "title": "Does a High-inflammatory Diet Increase the Risk of Inflammatory Bowel Disease? Results From the Prospective Urban Rural Epidemiology (PURE) Study: A Prospective Cohort Study",
        "url": "https://experts.mcmaster.ca/display/publication1981841",
        "journal": "Gastroenterology",
        "year": "2021",
        "doi": "10.1053/j.gastro.2021.06.007"
      },
      {
        "title": "Higher adalimumab maintenance regimen is more effective than standard dose in anti-TNF experienced Crohn’s disease patients",
        "url": "https://experts.mcmaster.ca/display/publication2124125",
        "journal": "European Journal of Gastroenterology and Hepatology",
        "year": "2021",
        "doi": "10.1097/meg.0000000000002250"
      },
      {
        "title": "Systematic review and meta‐analysis: Safety of vedolizumab during pregnancy in patients with inflammatory bowel disease",
        "url": "https://experts.mcmaster.ca/display/publication1981840",
        "journal": "Journal of Gastroenterology and Hepatology",
        "year": "2021",
        "doi": "10.1111/jgh.15574"
      },
      {
        "title": "Prevalence and Progression of Incidental Terminal Ileitis on Non-diagnostic Colonoscopy: A Systematic Review and Meta-analysis",
        "url": "https://experts.mcmaster.ca/display/publication1959560",
        "journal": "Journal of Crohn's and Colitis",
        "year": "2021",
        "doi": "10.1093/ecco-jcc/jjab030"
      },
      {
        "title": "Intake of artificial sweeteners among adults is associated with reduced odds of gastrointestinal luminal cancers: a meta-analysis of cohort and case-control studies",
        "url": "https://experts.mcmaster.ca/display/publication2124126",
        "journal": "Progress in Food and Nutrition Science",
        "year": "2021",
        "doi": "10.1016/j.nutres.2021.07.007"
      },
      {
        "title": "Medical Management Following Surgical Therapy in Inflammatory Bowel Disease: Evidence from Cochrane Reviews",
        "url": "https://experts.mcmaster.ca/display/publication1956936",
        "journal": "Inflammatory Bowel Diseases",
        "year": "2021",
        "doi": "10.1093/ibd/izaa350"
      },
      {
        "title": "A Microsimulation Model to Determine the Cost-Effectiveness of Treat-to-Target Strategies for Crohn's Disease",
        "url": "https://experts.mcmaster.ca/display/publication2135020",
        "journal": "American Journal of Gastroenterology",
        "year": "2021",
        "doi": "10.14309/ajg.0000000000001263"
      },
      {
        "title": "Association of ultra-processed food intake with risk of inflammatory bowel disease: prospective cohort study",
        "url": "https://experts.mcmaster.ca/display/publication2010132",
        "journal": "The BMJ",
        "year": "2021",
        "doi": "10.1136/bmj.n1554"
      },
      {
        "title": "End of Induction Patient-reported Outcomes Predict Clinical Remission but Not Endoscopic Remission in Crohn’s Disease",
        "url": "https://experts.mcmaster.ca/display/publication1939302",
        "journal": "Journal of Crohn's and Colitis",
        "year": "2021",
        "doi": "10.1093/ecco-jcc/jjaa242"
      },
      {
        "title": "Early life exposures and the risk of inflammatory bowel disease: Systematic review and meta-analyses",
        "url": "https://experts.mcmaster.ca/display/publication1971167",
        "journal": "EClinicalMedicine",
        "year": "2021",
        "doi": "10.1016/j.eclinm.2021.100884"
      },
      {
        "title": "The impact of ustekinumab on extraintestinal manifestations of Crohn's disease: Apost hocanalysis of the UNITI studies",
        "url": "https://experts.mcmaster.ca/display/publication1978971",
        "journal": "United European Gastroenterology Journal",
        "year": "2021",
        "doi": "10.1002/ueg2.12094"
      },
      {
        "title": "Body Mass Index Does Not Impact Clinical Efficacy of Ustekinumab in Crohn’s Disease: A Post Hoc Analysis of the IM-UNITI Trial",
        "url": "https://experts.mcmaster.ca/display/publication1923186",
        "journal": "Inflammatory Bowel Diseases",
        "year": "2021",
        "doi": "10.1093/ibd/izaa214"
      },
      {
        "title": "Editorial: methotrexate in patients with Crohn's disease refractory to anti‐TNF therapy—moving backwards yet forward?",
        "url": "https://experts.mcmaster.ca/display/publication1964782",
        "journal": "Alimentary Pharmacology and Therapeutics",
        "year": "2021",
        "doi": "10.1111/apt.16327"
      },
      {
        "title": "Week 6 Calprotectin Best Predicts Likelihood of Long-term Endoscopic Healing in Crohn’s Disease: A Post-hoc Analysis of the UNITI/IM-UNITI Trials",
        "url": "https://experts.mcmaster.ca/display/publication1926543",
        "journal": "Journal of Crohn's and Colitis",
        "year": "2021",
        "doi": "10.1093/ecco-jcc/jjaa189"
      },
      {
        "title": "Active Margins, Plexitis, and Granulomas Increase Postoperative Crohn’s Recurrence: Systematic Review and Meta-analysis",
        "url": "https://experts.mcmaster.ca/display/publication1923187",
        "journal": "Clinical Gastroenterology and Hepatology",
        "year": "2021",
        "doi": "10.1016/j.cgh.2020.08.014"
      },
      {
        "title": "Effect of Concomitant Therapy With Steroids and Tumor Necrosis Factor Antagonists for Induction of Remission in Patients With Crohn’s Disease: A Systematic Review and Pooled Meta-analysis",
        "url": "https://experts.mcmaster.ca/display/publication1916862",
        "journal": "Clinical Gastroenterology and Hepatology",
        "year": "2021",
        "doi": "10.1016/j.cgh.2020.06.036"
      },
      {
        "title": "Impact of Digital Health Monitoring in the Management of Inflammatory Bowel Disease",
        "url": "https://experts.mcmaster.ca/display/publication1956937",
        "journal": "Journal of Medical Systems",
        "year": "2021",
        "doi": "10.1007/s10916-021-01706-x"
      },
      {
        "title": "Mode of Delivery Does Not Affect the Risk of Inflammatory Bowel Disease",
        "url": "https://experts.mcmaster.ca/display/publication1701189",
        "journal": "Digestive Diseases and Sciences",
        "year": "2021",
        "doi": "10.1007/s10620-020-06204-7"
      },
      {
        "title": "Risk of Postoperative Infectious Complications From Medical Therapies in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis",
        "url": "https://experts.mcmaster.ca/display/publication1691591",
        "journal": "Inflammatory Bowel Diseases",
        "year": "2020",
        "doi": "10.1093/ibd/izaa020"
      },
      {
        "title": "Risk of postoperative infectious complications from medical therapies in inflammatory bowel disease",
        "url": "https://experts.mcmaster.ca/display/publication1935984",
        "journal": "Cochrane Database of Systematic Reviews",
        "year": "2020",
        "doi": "10.1002/14651858.cd013256.pub2"
      },
      {
        "title": "Ileal and Rectal Ulcer Size Affects the Ability to Achieve Endoscopic Remission: A Post hoc Analysis of the SONIC Trial",
        "url": "https://experts.mcmaster.ca/display/publication1920338",
        "journal": "American Journal of Gastroenterology",
        "year": "2020",
        "doi": "10.14309/ajg.0000000000000617"
      },
      {
        "title": "Higher vedolizumab serum levels do not increase the risk of adverse events in patients with inflammatory bowel disease",
        "url": "https://experts.mcmaster.ca/display/publication1915916",
        "journal": "Scandinavian Journal of Gastroenterology",
        "year": "2020",
        "doi": "10.1080/00365521.2020.1780470"
      },
      {
        "title": "Incorporating Fecal Calprotectin Into Clinical Practice for Patients With Moderate-to-Severely Active Ulcerative Colitis Treated With Biologics or Small-Molecule Inhibitors",
        "url": "https://experts.mcmaster.ca/display/publication1893561",
        "journal": "American Journal of Gastroenterology",
        "year": "2020",
        "doi": "10.14309/ajg.0000000000000596"
      },
      {
        "title": "Letter: mesalazine—a safe drug with rare serious adverse events? Authors’ reply",
        "url": "https://experts.mcmaster.ca/display/publication1905884",
        "journal": "Alimentary Pharmacology and Therapeutics",
        "year": "2020",
        "doi": "10.1111/apt.15748"
      },
      {
        "title": "Ulcerative Colitis Patients Continue to Improve Over the First Six Months of Vedolizumab Treatment: 12-Month Clinical and Mucosal Healing Effectiveness",
        "url": "https://experts.mcmaster.ca/display/publication1743441",
        "journal": "Journal of the Canadian Association of Gastroenterology",
        "year": "2020",
        "doi": "10.1093/jcag/gwy065"
      },
      {
        "title": "Prevalence of endoscopic improvement and remission according to patient‐reported outcomes in ulcerative colitis",
        "url": "https://experts.mcmaster.ca/display/publication1680386",
        "journal": "Alimentary Pharmacology and Therapeutics",
        "year": "2020",
        "doi": "10.1111/apt.15577"
      },
      {
        "title": "Is Blood Urea Concentration an Independent Predictor of Positive Endoscopic Findings in Presumed Upper Gastrointestinal Bleeding?",
        "url": "https://experts.mcmaster.ca/display/publication1654095",
        "journal": "Digestive Diseases",
        "year": "2020",
        "doi": "10.1159/000501549"
      },
      {
        "title": "Risk for development of inflammatory bowel disease under inhibition of interleukin 17: A systematic review and meta-analysis",
        "url": "https://experts.mcmaster.ca/display/publication1914162",
        "journal": "PLoS ONE",
        "year": "2020",
        "doi": "10.1371/journal.pone.0233781"
      },
      {
        "title": "Association Between Helicobacter pylori Exposure and Decreased Odds of Eosinophilic Esophagitis—A Systematic Review and Meta-analysis",
        "url": "https://experts.mcmaster.ca/display/publication1620999",
        "journal": "Clinical Gastroenterology and Hepatology",
        "year": "2019",
        "doi": "10.1016/j.cgh.2019.01.013"
      },
      {
        "title": "Response to Letter by Moulton et al.",
        "url": "https://experts.mcmaster.ca/display/publication1631396",
        "journal": "Inflammatory Bowel Diseases",
        "year": "2019",
        "doi": "10.1093/ibd/izz035"
      },
      {
        "title": "Systematic review with meta‐analysis: association betweenHelicobacter pyloriCagA seropositivity and odds of inflammatory bowel disease",
        "url": "https://experts.mcmaster.ca/display/publication1644604",
        "journal": "Alimentary Pharmacology and Therapeutics",
        "year": "2019",
        "doi": "10.1111/apt.15306"
      },
      {
        "title": "Anxiety But Not Depression Predicts Poor Outcomes in Inflammatory Bowel Disease",
        "url": "https://experts.mcmaster.ca/display/publication1618926",
        "journal": "Inflammatory Bowel Diseases",
        "year": "2019",
        "doi": "10.1093/ibd/izy385"
      },
      {
        "title": "Higher adalimumab serum levels do not increase the risk of adverse events in patients with inflammatory bowel disease",
        "url": "https://experts.mcmaster.ca/display/publication1643196",
        "journal": "Scandinavian Journal of Gastroenterology",
        "year": "2019",
        "doi": "10.1080/00365521.2019.1621367"
      },
      {
        "title": "Correction: Vedolizumab for Ulcerative Colitis: Treatment Outcomes from the VICTORY Consortium",
        "url": "https://experts.mcmaster.ca/display/publication1607289",
        "journal": "American Journal of Gastroenterology",
        "year": "2019",
        "doi": "10.1038/s41395-018-0401-4"
      },
      {
        "title": "Risk of postoperative infectious complications from medical therapies in inflammatory bowel disease",
        "url": "https://experts.mcmaster.ca/display/publication1747429",
        "journal": "Cochrane Database of Systematic Reviews",
        "year": "2019",
        "doi": "10.1002/14651858.cd013256"
      },
      {
        "title": "Patient-Reported Outcomes and Endoscopic Appearance of Ulcerative Colitis: A Systematic Review and Meta-analysis",
        "url": "https://experts.mcmaster.ca/display/publication1553059",
        "journal": "Clinical Gastroenterology and Hepatology",
        "year": "2019",
        "doi": "10.1016/j.cgh.2018.06.015"
      },
      {
        "title": "Impact of Adalimumab Patient Support Program’s Care Coach Calls on Clinical\n          Outcomes in Patients with Crohn’s Disease in Canada: An Observational Retrospective Cohort\n          Study",
        "url": "https://experts.mcmaster.ca/display/publication1652657",
        "journal": "Journal of the Canadian Association of Gastroenterology",
        "year": "2018",
        "doi": "10.1093/jcag/gwy059"
      },
      {
        "title": "Development and Validation of a Scoring System to Predict Outcomes of Vedolizumab Treatment in Patients With Crohn’s Disease",
        "url": "https://experts.mcmaster.ca/display/publication1543144",
        "journal": "Gastroenterology",
        "year": "2018",
        "doi": "10.1053/j.gastro.2018.05.039"
      },
      {
        "title": "Open: Vedolizumab for Ulcerative Colitis: Treatment Outcomes from the VICTORY Consortium",
        "url": "https://experts.mcmaster.ca/display/publication1561805",
        "journal": "American Journal of Gastroenterology",
        "year": "2018",
        "doi": "10.1038/s41395-018-0162-0"
      },
      {
        "title": "Safety of Propofol versus Nonpropofol-Based Sedation in Children Undergoing Gastrointestinal Endoscopy: A Systematic Review and Meta-Analysis",
        "url": "https://experts.mcmaster.ca/display/publication1590343",
        "journal": "Gastroenterology Research and Practice",
        "year": "2018",
        "doi": "10.1155/2018/6501215"
      },
      {
        "title": "The Role of Biomarkers in Clinical Trials of Inflammatory Bowel Disease",
        "url": "https://experts.mcmaster.ca/display/publication1543143",
        "journal": "Inflammatory Bowel Diseases",
        "year": "2018",
        "doi": "10.1093/ibd/izy195"
      },
      {
        "title": "Systematic review: safety of mesalazine in ulcerative colitis",
        "url": "https://experts.mcmaster.ca/display/publication1524689",
        "journal": "Alimentary Pharmacology and Therapeutics",
        "year": "2018",
        "doi": "10.1111/apt.14688"
      },
      {
        "title": "Role of endoscopy in inflammatory bowel disease",
        "url": "https://experts.mcmaster.ca/display/publication1543142",
        "journal": "Gastroenterology Report",
        "year": "2018",
        "doi": "10.1093/gastro/goy006"
      },
      {
        "title": "Systematic Review and Meta-Analysis: Preoperative Vedolizumab Treatment and Postoperative Complications in Patients with Inflammatory Bowel Disease",
        "url": "https://experts.mcmaster.ca/display/publication1524692",
        "journal": "Journal of Crohn's and Colitis",
        "year": "2018",
        "doi": "10.1093/ecco-jcc/jjy022"
      },
      {
        "title": "Enteral nutritional therapy for induction of remission in Crohn's disease",
        "url": "https://experts.mcmaster.ca/display/publication1514128",
        "journal": "Cochrane Database of Systematic Reviews",
        "year": "2018",
        "doi": "10.1002/14651858.cd000542.pub3"
      },
      {
        "title": "Systematic Review and Meta-analysis",
        "url": "https://experts.mcmaster.ca/display/publication1458956",
        "journal": "Inflammatory Bowel Diseases",
        "year": "2017",
        "doi": "10.1097/mib.0000000000001228"
      },
      {
        "title": "Systematic Review and Meta-analysis: Fecal Microbiota Transplantation for Treatment of Active Ulcerative Colitis.",
        "url": "https://experts.mcmaster.ca/display/publication1458955",
        "journal": "Inflammatory Bowel Diseases",
        "year": "2017",
        "doi": "10.1097/MIB.0000000000001228"
      },
      {
        "title": "Systematic review with meta‐analysis: proximal disease extension in limited ulcerative colitis",
        "url": "https://experts.mcmaster.ca/display/publication816946",
        "journal": "Alimentary Pharmacology and Therapeutics",
        "year": "2017",
        "doi": "10.1111/apt.14063"
      },
      {
        "title": "Trends in Narcotic and Corticosteroid Prescriptions in Patients with Inflammatory Bowel Disease in the United States Ambulatory Care Setting from 2003 to 2011",
        "url": "https://experts.mcmaster.ca/display/publication816948",
        "journal": "Inflammatory Bowel Diseases",
        "year": "2017",
        "doi": "10.1097/mib.0000000000001084"
      },
      {
        "title": "The morbidity and mortality of hepaticojejunostomies for complex bile duct injuries: a multi-institutional analysis of risk factors and outcomes using NSQIP",
        "url": "https://experts.mcmaster.ca/display/publication816961",
        "journal": "HPB",
        "year": "2017",
        "doi": "10.1016/j.hpb.2016.12.004"
      },
      {
        "title": "Review article: dose optimisation of infliximab for acute severe ulcerative colitis",
        "url": "https://experts.mcmaster.ca/display/publication816967",
        "journal": "Alimentary Pharmacology and Therapeutics",
        "year": "2017",
        "doi": "10.1111/apt.13913"
      },
      {
        "title": "Preventive care for a 35-year-old woman with inflammatory bowel disease",
        "url": "https://experts.mcmaster.ca/display/publication816957",
        "journal": "CANADIAN MEDICAL ASSOCIATION JOURNAL",
        "year": "2017",
        "doi": "10.1503/cmaj.160640"
      },
      {
        "title": "Impact of High-Dose Vitamin D3 Supplementation in Patients with Crohn’s Disease in Remission: A Pilot Randomized Double-Blind Controlled Study",
        "url": "https://experts.mcmaster.ca/display/publication485208",
        "journal": "Digestive Diseases and Sciences",
        "year": "2017",
        "doi": "10.1007/s10620-016-4396-7"
      },
      {
        "title": "Management Strategies to Improve Outcomes of Patients With Inflammatory Bowel Diseases",
        "url": "https://experts.mcmaster.ca/display/publication816986",
        "journal": "Gastroenterology",
        "year": "2017",
        "doi": "10.1053/j.gastro.2016.09.046"
      },
      {
        "title": "Letter: comparative safety and efficacy of infliximab vs. adalimumab in Crohn's disease – should one consider disease location? Authors’ reply",
        "url": "https://experts.mcmaster.ca/display/publication436492",
        "journal": "Alimentary Pharmacology and Therapeutics",
        "year": "2016",
        "doi": "10.1111/apt.13768"
      },
      {
        "title": "Mucosal Healing Is Associated With Improved Long-term Outcomes of Patients With Ulcerative Colitis: A Systematic Review and Meta-analysis",
        "url": "https://experts.mcmaster.ca/display/publication817000",
        "journal": "Clinical Gastroenterology and Hepatology",
        "year": "2016",
        "doi": "10.1016/j.cgh.2016.01.015"
      },
      {
        "title": "Reply",
        "url": "https://experts.mcmaster.ca/display/publication816996",
        "journal": "Clinical Gastroenterology and Hepatology",
        "year": "2016",
        "doi": "10.1016/j.cgh.2016.04.002"
      },
      {
        "title": "The Real-World Effectiveness and Safety of Vedolizumab for Moderate–Severe Crohn’s Disease: Results From the US VICTORY Consortium",
        "url": "https://experts.mcmaster.ca/display/publication799726",
        "journal": "American Journal of Gastroenterology",
        "year": "2016",
        "doi": "10.1038/ajg.2016.236"
      },
      {
        "title": "The efficacy and safety of either infliximab or adalimumab in 362 patients with anti‐TNF‐α naïve Crohn's disease",
        "url": "https://experts.mcmaster.ca/display/publication436500",
        "journal": "Alimentary Pharmacology and Therapeutics",
        "year": "2016",
        "doi": "10.1111/apt.13671"
      },
      {
        "title": "Letter: mucosal healing is associated with improved long‐term outcomes in Crohn's disease – authors' reply",
        "url": "https://experts.mcmaster.ca/display/publication816992",
        "journal": "Alimentary Pharmacology and Therapeutics",
        "year": "2016",
        "doi": "10.1111/apt.13637"
      },
      {
        "title": "Adverse Events During Anti-TNFα Therapies in IBD (Excluding Infections and Malignancies)",
        "url": "https://experts.mcmaster.ca/display/publication816998",
        "journal": "Inflammatory Bowel Diseases",
        "year": "2016",
        "doi": "10.1097/mib.0000000000000703"
      },
      {
        "title": "Systematic Review and Meta-Analysis: Infliximab or Cyclosporine as Rescue Therapy in Patients With Severe Ulcerative Colitis Refractory to Steroids",
        "url": "https://experts.mcmaster.ca/display/publication436508",
        "journal": "American Journal of Gastroenterology",
        "year": "2016",
        "doi": "10.1038/ajg.2016.7"
      },
      {
        "title": "Systematic review with meta‐analysis: mucosal healing is associated with improved long‐term outcomes in Crohn's disease",
        "url": "https://experts.mcmaster.ca/display/publication817003",
        "journal": "Alimentary Pharmacology and Therapeutics",
        "year": "2016",
        "doi": "10.1111/apt.13475"
      },
      {
        "title": "When to perform gastroscopy in the PSC patient",
        "url": "https://experts.mcmaster.ca/display/publication817002",
        "journal": "Annals of Hepatology",
        "year": "2016",
        "doi": "10.5604/16652681.1184294"
      },
      {
        "title": "Systematic Review",
        "url": "https://experts.mcmaster.ca/display/publication436558",
        "journal": "Inflammatory Bowel Diseases",
        "year": "2015",
        "doi": "10.1097/mib.0000000000000350"
      },
      {
        "title": "Management of Severe Ulcerative Colitis",
        "url": "https://experts.mcmaster.ca/display/publication817019",
        "journal": "Current Treatment Options in Gastroenterology",
        "year": "2015",
        "doi": "10.1007/s11938-014-0036-5"
      },
      {
        "title": "Anti-TNFα Therapies Are Safe During Pregnancy in Women with Inflammatory Bowel Disease",
        "url": "https://experts.mcmaster.ca/display/publication485256",
        "journal": "Inflammatory Bowel Diseases",
        "year": "2014",
        "doi": "10.1097/mib.0000000000000092"
      },
      {
        "title": "Combination Therapy With Methotrexate in Inflammatory Bowel Disease: Time to COMMIT?",
        "url": "https://experts.mcmaster.ca/display/publication817040",
        "journal": "Gastroenterology",
        "year": "2014",
        "doi": "10.1053/j.gastro.2014.01.040"
      },
      {
        "title": "Fecal Occult Blood Testing as a Diagnostic Test in Symptomatic Patients is not Useful: A Retrospective Chart Review",
        "url": "https://experts.mcmaster.ca/display/publication485246",
        "journal": "Canadian Journal of Gastroenterology and Hepatology",
        "year": "2014",
        "doi": "10.1155/2014/189652"
      },
      {
        "title": "Does acetylsalicylic acid or warfarin affect the accuracy of fecal occult blood tests?",
        "url": "https://experts.mcmaster.ca/display/publication485339",
        "journal": "Journal of Gastroenterology and Hepatology",
        "year": "2013",
        "doi": "10.1111/jgh.12201"
      },
      {
        "title": "Meta‐analysis: peri‐operative anti‐TNFα treatment and post‐operative complications in patients with inflammatory bowel disease",
        "url": "https://experts.mcmaster.ca/display/publication485365",
        "journal": "Alimentary Pharmacology and Therapeutics",
        "year": "2013",
        "doi": "10.1111/apt.12313"
      },
      {
        "title": "Meta‐analysis: colonoscopic post‐polypectomy bleeding in patients on continued clopidogrel therapy",
        "url": "https://experts.mcmaster.ca/display/publication485357",
        "journal": "Alimentary Pharmacology and Therapeutics",
        "year": "2013",
        "doi": "10.1111/apt.12292"
      },
      {
        "title": "An evaluation of the ‘5 Minute Medicine’ video podcast series compared to conventional medical resources for the internal medicine clerkship",
        "url": "https://experts.mcmaster.ca/display/publication811997",
        "journal": "Medical Teacher",
        "year": "2012",
        "doi": "10.3109/0142159x.2012.689446"
      },
      {
        "title": "Are Patients with Inflammatory Bowel Disease at Increased Risk of Coronary Artery Disease?",
        "url": "https://experts.mcmaster.ca/display/publication485371",
        "journal": "American Journal of Medicine",
        "year": "2012",
        "doi": "10.1016/j.amjmed.2012.03.015"
      },
      {
        "title": "Management of inflammatory bowel disease with vitamin D: Beyond bone health",
        "url": "https://experts.mcmaster.ca/display/publication485367",
        "journal": "Journal of Crohn's and Colitis",
        "year": "2012",
        "doi": "10.1016/j.crohns.2011.10.015"
      },
      {
        "title": "An Audit of Influenza Vaccination Status in Adults with Inflammatory Bowel Disease",
        "url": "https://experts.mcmaster.ca/display/publication485335",
        "journal": "Canadian Journal of Gastroenterology and Hepatology",
        "year": "2012",
        "doi": "10.1155/2012/158362"
      },
      {
        "title": "Should Albumin Be Used in All Patients with Spontaneous Bacterial Peritonitis?",
        "url": "https://experts.mcmaster.ca/display/publication485433",
        "journal": "Canadian Journal of Gastroenterology and Hepatology",
        "year": "2011",
        "doi": "10.1155/2011/586702"
      },
      {
        "title": "Role of probiotics in management of diverticular disease",
        "url": "https://experts.mcmaster.ca/display/publication485413",
        "journal": "Journal of Gastroenterology and Hepatology",
        "year": "2010",
        "doi": "10.1111/j.1440-1746.2010.06444.x"
      },
      {
        "title": "IgG4-Related Sclerosing Disease: A Novel Mimic of Inflammatory Bowel Disease",
        "url": "https://experts.mcmaster.ca/display/publication485417",
        "journal": "Digestive Diseases and Sciences",
        "year": "2010",
        "doi": "10.1007/s10620-010-1287-1"
      },
      {
        "title": "Should My Patient with Inflammatory Bowel Disease on Immunosuppressive Therapy be Vaccinated against Influenza Virus?",
        "url": "https://experts.mcmaster.ca/display/publication485472",
        "journal": "Canadian Journal of Gastroenterology and Hepatology",
        "year": "2010",
        "doi": "10.1155/2010/375878"
      },
      {
        "title": "Does Smoking Reduce Infliximab’s Effectiveness against Crohn’s Disease?",
        "url": "https://experts.mcmaster.ca/display/publication817129",
        "journal": "Canadian Journal of Gastroenterology and Hepatology",
        "year": "2009",
        "doi": "10.1155/2009/431349"
      },
      {
        "title": "Exercise and Inflammatory Bowel Disease",
        "url": "https://experts.mcmaster.ca/display/publication817141",
        "journal": "Canadian Journal of Gastroenterology and Hepatology",
        "year": "2008",
        "doi": "10.1155/2008/785953"
      }
    ],
    "chapters": [],
    "conferences": [
      {
        "title": "Adaptive Steroid Tapering Impedes Corticosteroid-free Remissions Compared with Forced Tapering in Clinical Trials of Ulcerative Colitis",
        "url": "https://experts.mcmaster.ca/display/publication3414760",
        "journal": "Journal of Crohn's and Colitis",
        "year": "2024",
        "doi": "10.1093/ecco-jcc/jjae092"
      },
      {
        "title": "Tofacitinib for hospitalized acute severe Ulcerative Colitis - the TRIUMPH study",
        "url": "https://experts.mcmaster.ca/display/publication3412884",
        "journal": "Crohn's and Colitis 360",
        "year": "2024",
        "doi": "10.1093/crocol/otaf013"
      },
      {
        "title": "The Performance of the Rutgeerts Score, SES-CD, and MM-SES-CD for Prediction of Postoperative Clinical Recurrence in Crohn’s Disease",
        "url": "https://experts.mcmaster.ca/display/publication2187540",
        "journal": "Inflammatory Bowel Diseases",
        "year": "2023",
        "doi": "10.1093/ibd/izac130"
      },
      {
        "title": "Comparative Effectiveness of Biologics for Endoscopic Healing of the Ileum and Colon in Crohn's Disease",
        "url": "https://experts.mcmaster.ca/display/publication2187537",
        "journal": "American Journal of Gastroenterology",
        "year": "2022",
        "doi": "10.14309/ajg.0000000000001795"
      },
      {
        "title": "Histologic remission does not offer additional benefit for ulcerative colitis patients in endoscopic remission",
        "url": "https://experts.mcmaster.ca/display/publication1702655",
        "journal": "Alimentary Pharmacology and Therapeutics",
        "year": "2020",
        "doi": "10.1111/apt.16147"
      },
      {
        "title": "WEEK 2 ADALIMUMAB LEVEL PREDICTS SHORT-TERM CLINICAL REMISSION IN PATIENTS WITH IBD",
        "url": "https://experts.mcmaster.ca/display/publication1644835",
        "journal": "Gastroenterology",
        "year": "2019"
      },
      {
        "title": "Mode of delivery and risk of inflammatory bowel disease",
        "url": "https://experts.mcmaster.ca/display/publication1634546",
        "journal": "Journal of Crohn's and Colitis",
        "year": "2019"
      },
      {
        "title": "Surveillance colonoscopies in ulcerative colitis: does it make a difference?",
        "url": "https://experts.mcmaster.ca/display/publication1634547",
        "journal": "Journal of Crohn's and Colitis",
        "year": "2019"
      },
      {
        "title": "P607 Higher adalimumab serum levels do not increase the risk of adverse events in patients with inflammatory bowel disease",
        "url": "https://experts.mcmaster.ca/display/publication1634545",
        "journal": "Journal of Crohn's and Colitis",
        "year": "2019",
        "doi": "10.1093/ecco-jcc/jjy222.731"
      },
      {
        "title": "Higher adalimumab maintenance regimens are more effective than standard maintenance doses in Crohn's disease patients who have failed infliximab",
        "url": "https://experts.mcmaster.ca/display/publication1518038",
        "journal": "Journal of Crohn's and Colitis",
        "year": "2018"
      },
      {
        "title": "Pre-operative vedolizumab treatment and postoperative complications in patients with inflammatory bowel disease: A systematic review and meta-analysis",
        "url": "https://experts.mcmaster.ca/display/publication1518039",
        "journal": "Journal of Crohn's and Colitis",
        "year": "2018"
      },
      {
        "title": "Systematic review and meta-analysis: Patient-reported outcomes and endoscopic appearance in ulcerative colitis",
        "url": "https://experts.mcmaster.ca/display/publication1515487",
        "journal": "Journal of Crohn's and Colitis",
        "year": "2018"
      },
      {
        "title": "Higher Adalimumab Maintenance Regimens Are More Effective Than Standard Maintenance Regimens in Crohnʼs Disease Patients Who Have Failed Infliximab",
        "url": "https://experts.mcmaster.ca/display/publication1581199",
        "journal": "American Journal of Gastroenterology",
        "year": "2017",
        "doi": "10.14309/00000434-201710001-00745"
      },
      {
        "title": "Systematic review with meta‐analysis: enteral nutrition therapy for the induction of remission in paediatric Crohn's disease",
        "url": "https://experts.mcmaster.ca/display/publication1080333",
        "journal": "Alimentary Pharmacology and Therapeutics",
        "year": "2017",
        "doi": "10.1111/apt.14253"
      },
      {
        "title": "Persistent Symptoms, CRP Elevation and Treatment Changes Over Time in Crohn's Disease Patients are Associated with Bowel Damage Progression as Expressed by Deterioration of Lemann Index Score",
        "url": "https://experts.mcmaster.ca/display/publication1333703",
        "journal": "Gastroenterology",
        "year": "2017",
        "doi": "10.1016/s0016-5085(17)32719-1"
      },
      {
        "title": "Proximal Disease Extension in Limited Ulcerative Colitis: A Systematic Review and Meta-Analysis",
        "url": "https://experts.mcmaster.ca/display/publication1333708",
        "journal": "Gastroenterology",
        "year": "2017",
        "doi": "10.1016/s0016-5085(17)33309-7"
      },
      {
        "title": "Ulcerative Colitis Patients on Vedolizumab Lacking Response at Induction Phase Continue to Improve Over the First 6 Months of Treatment",
        "url": "https://experts.mcmaster.ca/display/publication1333709",
        "journal": "Gastroenterology",
        "year": "2017",
        "doi": "10.1016/s0016-5085(17)31575-5"
      },
      {
        "title": "C-reactive protein improvement after vedolizumab induction phase is associated with remission after 6 months of treatment in ulcerative colitis patients",
        "url": "https://experts.mcmaster.ca/display/publication1333745",
        "journal": "Journal of Crohn's and Colitis",
        "year": "2017"
      },
      {
        "title": "Impact of adalimumab's patient support program on clinical outcomes in inflammatory bowel diseases: results from the COMPANION study",
        "url": "https://experts.mcmaster.ca/display/publication485172",
        "journal": "Journal of Crohn's and Colitis",
        "year": "2017"
      },
      {
        "title": "Persistent symptoms, CRP elevation and treatment changes over time in Crohn's disease patients are associated with bowel damage progression as expressed by deterioration of Lemann Index score",
        "url": "https://experts.mcmaster.ca/display/publication1333736",
        "journal": "Journal of Crohn's and Colitis",
        "year": "2017"
      },
      {
        "title": "Proximal Disease Extension in Limited Ulcerative Colitis: A Systematic Review and Meta-Analysis",
        "url": "https://experts.mcmaster.ca/display/publication1333734",
        "journal": "Inflammatory Bowel Diseases",
        "year": "2017"
      },
      {
        "title": "Proximal disease extension in limited ulcerative colitis: a systematic review and meta-analysis",
        "url": "https://experts.mcmaster.ca/display/publication1333742",
        "journal": "Journal of Crohn's and Colitis",
        "year": "2017"
      },
      {
        "title": "Trends in narcotic and corticosteroid prescriptions in patients with inflammatory bowel disease in the United States ambulatory care setting from 2003 to 2011",
        "url": "https://experts.mcmaster.ca/display/publication1333733",
        "journal": "Journal of Crohn's and Colitis",
        "year": "2017"
      },
      {
        "title": "Ulcerative colitis patients on vedolizumab lacking response at induction phase continue to improve over the first 6 months of treatment",
        "url": "https://experts.mcmaster.ca/display/publication1333738",
        "journal": "Journal of Crohn's and Colitis",
        "year": "2017"
      },
      {
        "title": "PUB006 Impact of the New WHO Classification of Thymic Tumors: Cross-Validation of the Prognostic Value in a Single Institution Cohort",
        "url": "https://experts.mcmaster.ca/display/publication1484036",
        "journal": "Journal of Thoracic Oncology",
        "year": "2017",
        "doi": "10.1016/j.jtho.2016.11.1976"
      },
      {
        "title": "Prognostic Value of the New WHO Thymoma Classification: Single institution Cross Validation Study",
        "url": "https://experts.mcmaster.ca/display/publication1511865",
        "journal": "Journal of Thoracic Oncology",
        "year": "2016",
        "doi": "10.1016/j.jtho.2016.09.061"
      },
      {
        "title": "Outcomes of Second- and Third-LineTumor Necrosis Factor-Î± Antagonists in Inflammatory Bowel Disease",
        "url": "https://experts.mcmaster.ca/display/publication1333728",
        "journal": "American Journal of Gastroenterology",
        "year": "2016",
        "doi": "10.14309/00000434-201610001-00985"
      },
      {
        "title": "Rho Kinase Ezpression in Giant Cell Arteritis: Validating Perm Intensity Score As a Method of Increasing Sensitivity of Temporal Artery Biopsy",
        "url": "https://experts.mcmaster.ca/display/publication1489861",
        "journal": "Arthritis & Rheumatology",
        "year": "2016"
      },
      {
        "title": "Sa1888 Efficacy and Predictors of Outcomes of Vedolizumab for Ulcerative Colitis in Clinical Practice",
        "url": "https://experts.mcmaster.ca/display/publication1320061",
        "journal": "Gastroenterology",
        "year": "2016",
        "doi": "10.1016/s0016-5085(16)31377-4"
      },
      {
        "title": "Sa1889 Efficacy and Predictors of Outcomes of Vedolizumab for Crohn's Disease in Clinical Practice",
        "url": "https://experts.mcmaster.ca/display/publication1320068",
        "journal": "Gastroenterology",
        "year": "2016",
        "doi": "10.1016/s0016-5085(16)31378-6"
      },
      {
        "title": "Tu1908 Safety of Vedolizumab in Inflammatory Bowel Disease in a Multi-Center Real World Consortium",
        "url": "https://experts.mcmaster.ca/display/publication1320067",
        "journal": "Gastroenterology",
        "year": "2016",
        "doi": "10.1016/s0016-5085(16)33301-7"
      },
      {
        "title": "Impact of high-dose vitamin D3 supplementation in treatment of Crohn's disease in remission: a randomised double-blind controlled study",
        "url": "https://experts.mcmaster.ca/display/publication1333746",
        "journal": "Journal of Crohn's and Colitis",
        "year": "2016"
      },
      {
        "title": "Mucosal Healing Is Associated with Improved Long-Term Outcomes in Crohn's Disease: A Systematic Review and Meta-analysis",
        "url": "https://experts.mcmaster.ca/display/publication1333731",
        "journal": "Inflammatory Bowel Diseases",
        "year": "2016"
      },
      {
        "title": "Mucosal Healing Is Associated with Improved Long-Term Outcomes in Ulcerative Colitis: A Systematic Review and Meta-analysis",
        "url": "https://experts.mcmaster.ca/display/publication1333724",
        "journal": "Inflammatory Bowel Diseases",
        "year": "2016"
      },
      {
        "title": "P-064 Impact of High Dose Vitamin D3 Supplementation in Treatment of Crohnʼs Disease in Remission",
        "url": "https://experts.mcmaster.ca/display/publication1333735",
        "journal": "Inflammatory Bowel Diseases",
        "year": "2016",
        "doi": "10.1097/01.mib.0000480168.31416.a6"
      },
      {
        "title": "Mucosal Healing Is Associated With Improved Long-Term Outcomes in Ulcerative Colitis: A Systematic Review and Meta-analysis Presidential Poster",
        "url": "https://experts.mcmaster.ca/display/publication1333748",
        "journal": "American Journal of Gastroenterology",
        "year": "2015",
        "doi": "10.14309/00000434-201510001-01953"
      },
      {
        "title": "Vedolizumab for Moderate to Severely Active Inflammatory Bowel Disease: A Multicenter U.S. Consortium",
        "url": "https://experts.mcmaster.ca/display/publication1333760",
        "journal": "American Journal of Gastroenterology",
        "year": "2015",
        "doi": "10.14309/00000434-201510001-01904"
      },
      {
        "title": "Systematic Review and Meta-Analysis: Infliximab or Ciclosporin as Rescue Therapy in Patients with Severe Ulcerative Colitis Refractory to Steroids",
        "url": "https://experts.mcmaster.ca/display/publication932574",
        "journal": "Journal of Crohn's and Colitis",
        "year": "2015"
      },
      {
        "title": "Infliximab or Cyclosporine as Rescue Therapy in Patients With Severe Ulcerative Colitis Refractory to Steroids: A Systematic Review and Meta-Analysis",
        "url": "https://experts.mcmaster.ca/display/publication932568",
        "journal": "American Journal of Gastroenterology",
        "year": "2014",
        "doi": "10.14309/00000434-201410002-01772"
      },
      {
        "title": "Anti-TNF alpha Therapies Are Safe During Pregnancy in Women With Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis",
        "url": "https://experts.mcmaster.ca/display/publication485182",
        "journal": "Gastroenterology",
        "year": "2014"
      },
      {
        "title": "DOP040 Anti-TNF-α therapies are safe during pregnancy in patients with inflammatory bowel disease: a meta-analysis",
        "url": "https://experts.mcmaster.ca/display/publication1333751",
        "journal": "Journal of Crohn's and Colitis",
        "year": "2014",
        "doi": "10.1016/s1873-9946(14)60065-9"
      },
      {
        "title": "An Audit of Fecal Occult Blood Testing in Hospital Inpatients",
        "url": "https://experts.mcmaster.ca/display/publication610307",
        "journal": "American Journal of Gastroenterology",
        "year": "2013",
        "doi": "10.14309/00000434-201310001-01650"
      },
      {
        "title": "Peri-operative Anti-TNFα Treatment and Post-operative Complications in Patients with Inflammatory Bowel Disease: A Systematic Review and Meta-analysis",
        "url": "https://experts.mcmaster.ca/display/publication1333777",
        "journal": "American Journal of Gastroenterology",
        "year": "2013",
        "doi": "10.14309/00000434-201310001-01824"
      }
    ],
    "other": [
      {
        "title": "Interim Analysis of a Trial Evaluating the Utility of Non-Targeted Biopsies for Colorectal Neoplasia Detection in Inflammatory Bowel Disease",
        "url": "https://experts.mcmaster.ca/display/publication3445727",
        "journal": "Clinical Gastroenterology and Hepatology",
        "year": "2024",
        "doi": "10.1016/j.cgh.2023.12.007"
      }
    ],
    "preprints": []
  },
  "filename": "Neeraj_Narula.json",
  "file_created": "2025-07-27T15:11:22.863624"
}